Acetic acid derivatives and related substances

RX_ACETICDERIV

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Medicine purchases: ATC — M01AB 1 out of 7 registries used, show all original rules.	121354
4. Check minimum number of events Min. number of events 3	121354
5. Include endpoints None	121354
6. Filter based on genotype QC (FinnGen only)	117469

Control definitions (FinnGen only)

Control exclude: RX_NSAID

Extra metadata

First used in FinnGen datafreeze: DF4

NAME	RX_ACETICDERIV
CONTROL_EXCLUDE	RX_NSAID
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC	M01AB
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Acetic acid derivatives and related substances based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	117469	70044	47425
Unadjusted period prevalence (%)	23.59	24.85	21.73
Median age at first event (years)	44.43	43.20	46.25

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
18653: Matched controls
96822

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M01AE52

ATC

naproxen and esomeprazole; oral

22.0

321.9

387

R4110

NOMESCO Finland

Physiotherapy

2.2

320.5

4055

11044

L90

ICPC

Osteoarthrosis of knee

6.6

315.6

703

571

J01DA09

ATC

[U] cefadroxil

2.1

315.2

4020

10975

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

2.3

315.2

3242

8078

D07AC13

ATC

mometasone; topical

2.1

314.5

4193

11651

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.9

312.1

6175

19823

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

8.8

311.8

565

344

N05BA01

ATC

diazepam; systemic, rectal

2.8

311.5

2023

3997

R06AX22

ATC

ebastine; oral

2.7

307.7

2324

4784

M01AH01

ATC

celecoxib; oral

20.1

307.7

3059

938

J01FF01

ATC

clindamycin; systemic

2.6

307.7

4163

9581

J01CE02

ATC

phenoxymethylpenicillin; oral

2.2

307.7

11248

39112

M54.6

ICD-10 Finland

Pain in thoracic spine

5.2

307.7

1108

1168

M54.3

ICD-10 Finland

Sciatica

7.7

307.7

868

609

R52.9

ICD-10 Finland

Pain, unspecified

3.8

307.7

1453

2127

R01AD58

ATC

fluticasone, combinations; nasal

3.1

307.7

3635

6998

A02BC02

ATC

pantoprazole; systemic

3.9

307.7

11857

29932

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

4.0

307.7

1386

1896

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

6.9

307.7

926

724

ZXA00

NOMESCO Finland

Right side

2.4

307.7

3858

9358

P01BA02

ATC

hydroxychloroquine; oral

5.5

307.7

966

955

M17.0

ICD-10 Finland

Primary gonarthrosis, bilateral

8.6

307.7

2045

1369

M54

ICD-10 Finland

Dorsalgia

5.9

307.7

2290

2230

M01AX17

ATC

nimesulide; oral

12.5

307.7

3957

2044

J01.0

ICD-10 Finland

Acute maxillary sinusitis

3.2

307.7

3670

6936

A02BA02

ATC

ranitidine; systemic

2.8

307.7

2913

6083

D07AC01

ATC

betamethasone; topical

2.0

307.7

5249

15574

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

10.3

307.7

890

470

X59

ICD-10 Finland

Exposure to unspecified factor

3.0

307.7

2997

5799

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

10.7

307.7

1243

640

F51.0

ICD-10 Finland

Nonorganic insomnia

3.1

307.7

2498

4656

M03BC51

ATC

orphenadrine, combinations; systemic

8.3

307.7

5067

4162

S18

ICPC

Laceration/cut

2.2

307.7

6745

19830

M01AB51

ATC

indometacin, combinations; oral, rectal

26.5

307.7

503

101

P01AB01

ATC

metronidazole; oral, rectal

2.5

307.7

5894

15169

R05FB02

ATC

cough suppressants and expectorants; systemic

2.7

307.7

5761

13757

N02AJ06

ATC

codeine and paracetamol; systemic

5.8

307.7

7571

10200

M01AB01

ATC

indometacin; systemic, rectal

23.0

307.7

2438

630

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

2.8

307.7

4117

8979

R06AE07

ATC

cetirizine; oral

2.4

307.7

6873

19065

R01BA52

ATC

pseudoephedrine, combinations; oral

3.1

307.7

3939

7674

R10.1

ICD-10 Finland

Pain localized to upper abdomen

3.0

307.7

2561

4939

ZXE10

NOMESCO Finland

More than one and less than three hours

2.3

307.7

5437

14671

M02AA07

ATC

piroxicam; topical

6.6

307.7

6525

7297

R06.0

ICD-10 Finland

Dyspnoea

2.3

307.7

4128

10485

M53.0

ICD-10 Finland

Cervicocranial syndrome

5.5

307.7

1368

1367

L02

ICPC

Back symptom/complaint

4.0

307.7

1585

2214

G56.0

ICD-10 Finland

Carpal tunnel syndrome

5.9

307.7

1915

1848

S46.0

ICD-10 Finland

Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder

5.6

307.7

1128

1101

A02BC01

ATC

omeprazole; systemic

2.8

307.7

4605

10186

G47.3

ICD-10 Finland

Sleep apnoea

2.8

307.7

3058

6403

J01FA06

ATC

roxithromycin; oral

2.7

307.7

6248

15426

S83.2

ICD-10 Finland

Tear of meniscus, current

5.8

307.7

932

864

ACC51

NOMESCO Finland

Release of median nerve

6.4

307.7

887

746

N06CA01

ATC

amitriptyline and psycholeptics; systemic

5.0

307.7

1457

1598

M17.1

ICD-10 Finland

Other primary gonarthrosis

7.9

307.7

3134

2407

J01MA02

ATC

ciprofloxacin; systemic

2.3

307.7

6330

17756

B01AB05

ATC

enoxaparin; parenteral

2.2

307.7

4324

11829

G43

ICD-10 Finland

Migraine

8.2

307.7

817

541

G43.9

ICD-10 Finland

Migraine, unspecified

7.3

307.7

949

705

L04AX03

ATC

methotrexate; systemic

4.6

307.7

1244

1470

M01AH05

ATC

etoricoxib; oral

19.7

307.7

11422

7176

M01AX01

ATC

nabumetone; oral

18.4

307.7

556

161

N06AX11

ATC

mirtazapine; oral

2.8

307.7

5468

12552

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

2.0

307.7

8208

27509

L86

ICPC

Back syndrome with radiating pain

7.4

307.7

902

656

M09AX01

ATC

hyaluronic acid; parenteral

16.3

307.7

795

263

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

9.3

307.7

945

554

NGB20

NOMESCO Finland

Primary total prosthetic replacement of knee joint without patellar part

11.9

307.7

1507

710

SAA01

NOMESCO Finland

Simple examination of mouth

1.9

307.7

11110

42350

M54.4

ICD-10 Finland

Lumbago with sciatica

8.5

307.7

3140

2250

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

307.7

6804

22076

M23.2

ICD-10 Finland

Derangement of meniscus due to old tear or injury

7.1

307.7

1466

1146

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

4.7

307.7

1614

1907

WX320

NOMESCO Finland

Spinalanesthesy

2.9

307.7

3485

7169

R01AD08

ATC

fluticasone; nasal

2.7

307.7

4365

9741

M16.1

ICD-10 Finland

Other primary coxarthrosis

6.3

307.7

1618

1434

ABC16

NOMESCO Finland

Microsurgical excision of lumbar intervertebral disc displacement

16.9

307.7

537

170

L17

ICPC

Foot/toe symptom/complaint

2.6

307.7

4238

9775

ZXA05

NOMESCO Finland

Left side

2.4

307.7

3581

8785

C07AA05

ATC

propranolol; systemic

2.5

307.7

2968

6853

R03AK07

ATC

formoterol and budesonide; inhalant

3.0

307.7

3061

6010

M01AE03

ATC

ketoprofen; systemic, rectal

8.4

307.7

6496

5799

R74

ICPC

Upper respiratory infection acute

2.1

307.7

4807

13752

M04AA01

ATC

allopurinol; systemic

2.9

307.7

2316

4557

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.0

307.7

6993

22065

N02BF02

ATC

pregabalin; oral

6.4

307.7

865

731

M01AB08

ATC

etodolac; oral

24.6

307.7

1444

329

M79.6

ICD-10 Finland

Pain in limb

4.3

307.7

7090

12088

OAA65, ,

SPAT

2.8

307.7

2304

4692

A02BC03

ATC

lansoprazole; oral

3.3

307.7

4546

8676

L08

ICPC

Shoulder symptom/complaint

4.1

307.7

3206

4696

N06AX21

ATC

duloxetine; oral

5.8

307.7

1838

1787

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

2.5

307.7

8002

22593

H02AB06

ATC

prednisolone; systemic

2.7

307.7

7998

20849

J01FA10

ATC

azithromycin; systemic

2.9

307.7

9468

25336

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

8.2

307.7

1658

1140

NGD05

NOMESCO Finland

Partial excision of meniscus of knee, arthroscopic

7.3

307.7

1532

1172

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

2.6

307.7

8594

23694

M01AX05

ATC

glucosamine; oral

23.9

307.7

2875

732

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

2.3

307.7

6093

16635

M19.0

ICD-10 Finland

Primary arthrosis of other joints

8.0

307.7

1306

905

N02AX02

ATC

tramadol; systemic, rectal

6.9

307.7

8704

10924

M01AB16

ATC

aceclofenac; oral

28.7

307.7

553

103

M54.9

ICD-10 Finland

Dorsalgia, unspecified

5.7

307.7

2182

2193

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.6

307.7

2909

6502

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.8

307.7

6144

14352

WX110

NOMESCO Finland

Infiltration anesthesia

1.9

307.7

11277

42805

A07EC01

ATC

sulfasalazine; oral, rectal

7.5

307.7

1234

908

N06AA09

ATC

amitriptyline; systemic

6.1

307.7

1468

1345

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

7.4

307.7

8633

10088

A06AC01

ATC

ispaghula (psylla seeds); oral

3.0

307.7

3855

7835

H02BX01

ATC

methylprednisolone, combinations; systemic

8.4

307.7

760

490

N05CF02

ATC

zolpidem; oral

3.7

307.7

2582

4010

M01AC01

ATC

piroxicam; systemic, rectal

10.2

307.7

1951

1095

M01AB55

ATC

diclofenac, combinations; oral

34.8

307.7

1687

276

N02BF01

ATC

gabapentin; oral

6.9

307.7

1161

924

N06AX16

ATC

venlafaxine; oral

3.1

307.7

2075

3713

N02CC03

ATC

zolmitriptan; nasal, oral

9.1

307.7

674

399

M01AE01

ATC

ibuprofen; systemic, rectal

8.5

307.7

15771

38004

M01AB05

ATC

diclofenac; systemic, rectal

119.2

307.7

17546

11366

NBG15

NOMESCO Finland

Acromioplastia, arthroscopic

12.1

307.7

756

336

J01DA01

ATC

[U] cefalexin

2.6

307.7

10631

32525

M54.5

ICD-10 Finland

Low back pain

5.9

307.7

6772

8536

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

10.4

307.7

2528

1439

M77.1

ICD-10 Finland

Lateral epicondylitis

8.0

307.7

1067

728

ZXE00

NOMESCO Finland

One hour or less

2.1

307.7

6111

18246

M79.7

ICD-10 Finland

Fibromyalgia

14.8

307.7

463

166

N02CC07

ATC

frovatriptan; oral

11.5

307.7

533

247

A02BC05

ATC

esomeprazole; systemic

3.7

307.7

6690

12636

N02CC06

ATC

eletriptan; oral

13.8

307.7

462

178

M01AC06

ATC

meloxicam; systemic, rectal

15.9

307.7

6184

2937

J01FA09

ATC

clarithromycin; systemic

3.1

307.7

4684

9486

M25.5

ICD-10 Finland

Pain in joint

5.6

307.7

5334

6495

R01AD12

ATC

fluticasone furoate; nasal

2.9

307.7

4647

10049

M01AE11

ATC

tiaprofenic acid; oral, rectal

15.4

307.7

578

201

M01AH03

ATC

valdecoxib; oral

19.1

307.7

766

217

J02AC01

ATC

fluconazole; systemic

2.5

307.7

5280

12994

ABC36

NOMESCO Finland

Decompression of lumbar nerve roots

12.2

307.7

758

335

L13

ICPC

Hip symptom/complaint

4.2

307.7

2429

3361

M01AC02

ATC

tenoxicam; systemic, rectal

9.7

307.7

594

327

M72.2

ICD-10 Finland

Plantar fascial fibromatosis

5.7

307.7

1044

990

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

6.1

307.7

877

772

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

7.5

307.7

891

644

A01

ICPC

Pain general/multiple sites

3.8

307.7

1350

1965

L03

ICPC

Low back symptom/complaint

4.3

307.7

4765

7112

N02BE01

ATC

paracetamol; systemic, rectal

6.2

307.7

15918

46998

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.2

307.7

4938

13740

J01CA04

ATC

amoxicillin; systemic

2.5

307.7

14022

53153

M53.1

ICD-10 Finland

Cervicobrachial syndrome

6.2

307.7

1804

1636

M23.9

ICD-10 Finland

Internal derangement of knee, unspecified

4.7

307.7

1233

1433

L12

ICPC

Hand/finger symptom/complaint

2.9

307.7

2344

4538

NFB30

NOMESCO Finland

Primary total prosthetic replacement of hip joint not using cement

7.6

307.7

810

577

G44.2

ICD-10 Finland

Tension-type headache

5.0

307.7

2175

2475

M03BX02

ATC

tizanidine; oral

11.3

307.7

12138

13663

J01DB01

ATC

cefalexin; oral

3.2

307.7

14351

49221

L01

ICPC

Neck symptom/complaint

3.9

307.7

2397

3547

M75.1

ICD-10 Finland

Rotator cuff syndrome

6.7

307.7

4015

3819

N05CF01

ATC

zopiclone; oral

2.7

307.7

5428

12765

M02AA15

ATC

diclofenac; topical

8.5

307.7

1161

748

NGF25

NOMESCO Finland

Operation for osteochondritis of knee, arthroscopic

11.6

307.7

880

412

L15

ICPC

Knee symptom/complaint

3.9

307.7

3438

5342

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.3

307.7

3409

8489

NJ2MA

NOMESCO Finland

Measurement of mechanical axis of lower leg with X-ray

10.8

307.7

805

402

NBL00

NOMESCO Finland

Suture or reinsertation of rotator cuff of shoulder

8.9

307.7

643

388

N03AX16

ATC

[U] pregabalin

7.0

307.7

4284

3962

M01AG02

ATC

tolfenamic acid; oral, rectal

10.6

307.7

1943

1053

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

4.5

307.7

2355

3033

M15.9

ICD-10 Finland

Polyarthrosis, unspecified

7.4

307.7

710

513

R51.80

ICD-10 Finland

Headache

4.4

307.7

2649

3509

R05DA20

ATC

opium alkaloids and derivatives - combinations

2.5

307.7

3923

9490

J01AA02

ATC

doxycycline; systemic

3.8

307.7

13392

39104

M01AH02

ATC

rofecoxib; oral

15.7

307.7

2061

761

R07.4

ICD-10 Finland

Chest pain, unspecified

2.6

307.7

4174

9660

M16.0

ICD-10 Finland

Primary coxarthrosis, bilateral

6.8

307.7

993

798

R05FA02

ATC

opium derivatives and expectorants; systemic

2.6

307.7

6298

15833

M54.2

ICD-10 Finland

Cervicalgia

6.5

307.7

1212

1029

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

7.2

307.7

2200

1755

M01AE02

ATC

naproxen; oral, rectal

11.3

307.7

10639

10173

ZXD10

NOMESCO Finland

Scheduled procedure

2.2

307.7

5832

16354

M70.6

ICD-10 Finland

Trochanteric bursitis

7.5

307.7

1671

1247

R03AC02

ATC

salbutamol; inhalant

2.7

307.7

9039

25006

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

2.1

307.7

4575

12902

N02CC04

ATC

rizatriptan; oral

8.7

307.7

684

422

R01AD09

ATC

mometasone; nasal

3.1

307.7

7318

16857

R03DC03

ATC

montelukast; oral

2.8

307.7

2212

4453

X58

ICD-10 Finland

Exposure to other specified factors

3.3

307.7

2219

3825

NGA30

NOMESCO Finland

Exploration of knee joint, arthroscopic

8.3

307.7

659

423

M17

ICD-10 Finland

Gonarthrosis [arthrosis of knee]

6.1

307.7

1341

1223

M02AA10

ATC

ketoprofen; topical

6.3

307.7

2586

2406

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

5.3

307.7

1686

1776

M03BC01

ATC

orphenadrine (citrate); systemic

11.1

307.7

4535

2712

N05BA04

ATC

oxazepam; oral

2.4

307.7

4185

10277

M79.1

ICD-10 Finland

Myalgia

4.8

307.7

2398

2868

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

3.2

307.7

3661

6855

N03AX12

ATC

[U] gabapentin; oral

7.7

307.7

2818

2179

R06AX27

ATC

desloratadine; oral

2.7

307.7

4236

9408

M48.0

ICD-10 Finland

Spinal stenosis

7.2

307.7

1999

1592

M17.9

ICD-10 Finland

Gonarthrosis, unspecified

5.4

307.7

1486

1521

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

8.9

307.0

552

332

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

306.6

4237

11924

R42

ICD-10 Finland

Dizziness and giddiness

2.3

306.3

3371

8642

G04CA01

ATC

alfuzosin; oral

2.7

303.5

2084

4245

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.3

300.9

3052

7543

N01

ICPC

Headache

3.0

299.4

1785

3352

N02CC05

ATC

almotriptan; oral

10.3

298.4

491

254

M15

ICD-10 Finland

Polyarthrosis

7.9

297.9

578

390

Z3226

NOMESCO Finland

Physiotherapist

2.4

296.4

2717

6406

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

2.1

294.0

4281

12265

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

6.1

290.9

692

608

A02BC04

ATC

rabeprazole; oral

4.0

290.8

1083

1467

NA3BG, ,

SPAT

8.3

288.7

540

345

M05.8

ICD-10 Finland

Other seropositive rheumatoid arthritis

6.6

287.9

640

518

Z96.6

ICD-10 Finland

Presence of orthopaedic joint implants

8.9

287.6

516

309

L16

ICPC

Ankle symptom/complaint

3.1

287.3

1596

2868

N89

ICPC

Migraine

7.5

285.6

577

412

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.5

283.9

2343

5243

R53

ICD-10 Finland

Malaise and fatigue

2.1

279.5

3850

10771

C05AA08

ATC

fluocortolone; rectal, topical

2.8

277.9

1784

3491

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

15.1

277.9

380

133

T84.0

ICD-10 Finland

Mechanical complication of internal joint prosthesis

9.5

277.6

479

269

R05

ICD-10 Finland

Cough

2.3

274.1

2813

6964

M13.9

ICD-10 Finland

Arthritis, unspecified

4.2

273.3

965

1250

WX408

NOMESCO Finland

General anesthesy, balanced

2.1

272.9

3642

10054

E0000UV, ,

ATC

1.8

272.5

6145

20390

NG1AA, ,

SPAT

5.2

270.4

740

757

S01GX01

ATC

cromoglicic acid; ophthalmic

2.3

269.7

2670

6501

R51

ICD-10 Finland

Headache

4.6

268.9

844

986

L01BA01

ATC

methotrexate; systemic

9.8

268.7

454

246

N02AA05

ATC

oxycodone; systemic

2.3

268.3

2608

6297

M75.9

ICD-10 Finland

Shoulder lesion, unspecified

5.8

268.2

667

616

N06AB04

ATC

citalopram; systemic

2.2

267.2

3031

7827

N06AB10

ATC

escitalopram; oral

2.2

266.4

3062

7951

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

15.6

265.4

358

121

D07AB02

ATC

hydrocortisone butyrate; topical

2.0

264.9

4212

12399

NGB40

NOMESCO Finland

Primary total prosthetic replacement of knee joint with patellar part - sliding prosthesis

16.0

264.7

354

117

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

12.8

264.6

389

161

E66.01

ICD-10 Finland

Obesity due to excess calories

3.5

262.0

1181

1845

G55.1*M51.1

ICD-10 Finland

Compression of nerve roots and nerve plexus in disc diseases in the lumbar region and other regions

10.9

260.9

416

203

GD1AA, ,

SPAT

3.0

260.3

1534

2852

C09CA06

ATC

candesartan; oral

2.2

260.2

3087

8114

M76.6

ICD-10 Finland

Achilles tendinitis

5.8

259.8

649

602

NA3EA

NOMESCO Finland

Lumbar spine X-ray examination with flexion

12.8

259.7

381

157

J20

ICD-10 Finland

Acute bronchitis

3.1

259.4

1371

2383

J05AB01

ATC

aciclovir; systemic

2.2

258.1

2946

7618

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

4.1

257.2

936

1242

M75

ICD-10 Finland

Shoulder lesions

6.3

256.0

588

495

R05

ICPC

Cough

2.1

256.0

3264

8827

G04CA02

ATC

tamsulosin; oral

2.0

255.5

4065

11949

R52.2

ICD-10 Finland

Other chronic pain

7.5

253.6

509

360

M47.82

ICD-10 Finland

Other spondylosis, cervical region

8.1

253.4

481

314

M75.0

ICD-10 Finland

Adhesive capsulitis of shoulder

5.3

252.4

677

678

M45

ICD-10 Finland

Ankylosing spondylitis

16.7

252.3

332

105

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.8

251.8

5511

18018

L28

ICPC

Limited function/disability (L)

2.3

251.1

2534

6208

A03FA01

ATC

metoclopramide; systemic, rectal

2.2

249.5

2932

7665

M23.8

ICD-10 Finland

Other internal derangements of knee

7.7

246.7

488

338

M79.0

ICD-10 Finland

Rheumatism, unspecified

11.6

244.7

377

172

M54.1

ICD-10 Finland

Radiculopathy

7.2

240.9

500

370

N05BA12

ATC

alprazolam; oral

3.0

240.4

1363

2472

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

2.4

240.1

2226

5241

K30

ICD-10 Finland

Functional dyspepsia

2.9

240.1

1453

2740

WX002

NOMESCO Finland

Sedation and analgesia

2.2

240.0

2632

6676

R03BA05

ATC

fluticasone; inhalant

2.2

238.7

2625

6665

NG1BG

NOMESCO Finland

Knee and lower leg MRI examination with high intensity magnet

6.5

237.1

532

435

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

3.3

236.3

1131

1839

L84

ICPC

Back syndrome without radiat pain

4.9

234.6

682

740

OAB91, ,

SPAT

4.1

233.8

845

1114

D01BA02

ATC

terbinafine; oral

2.0

233.6

3430

9753

SPAT1153

SPAT

Removal of sutures

1.9

233.3

4109

12460

N05AH04

ATC

quetiapine; oral

2.1

232.9

2853

7567

N02AC04

ATC

dextropropoxyphene; oral

5.1

231.5

646

673

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

9.3

231.5

402

228

M54.8

ICD-10 Finland

Other dorsalgia

5.2

231.2

635

651

K10.3

ICD-10 Finland

Alveolitis of jaws

5.1

230.2

648

681

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

3.1

229.9

1210

2093

S80.0

ICD-10 Finland

Contusion of knee

3.5

229.5

1032

1606

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.2

229.5

2553

6505

M01AG01

ATC

mefenamic acid; oral

16.6

229.1

302

J01DA06

ATC

[U] cefuroxime

2.4

228.7

1988

4536

WX290

NOMESCO Finland

Other blockage of nerve

1.7

228.1

6880

24578

J01FA15

ATC

telithromycin; oral

3.2

227.3

1140

1911

SFA20

NOMESCO Finland

Two-surface restoration

1.7

227.0

8453

31976

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

3.4

225.4

1066

1718

J45.9

ICD-10 Finland

Asthma, unspecified

2.2

225.4

2618

6788

M77.4

ICD-10 Finland

Metatarsalgia

4.6

225.3

701

811

M16.9

ICD-10 Finland

Coxarthrosis, unspecified

4.9

225.1

654

709

G04BD12

ATC

mirabegron; oral

2.8

224.1

1424

2758

D01

ICPC

Abdominal pain/cramps general

2.6

222.9

1694

3614

NF1AA

NOMESCO Finland

Hip X-ray examination

3.3

221.6

1099

1828

S93.4

ICD-10 Finland

Sprain and strain of ankle

2.7

220.0

1563

3218

I10

ICD-10 Finland

Essential (primary) hypertension

1.7

220.0

8542

32578

D11

ICPC

Diarrhoea

2.5

219.7

1753

3832

L11

ICPC

Wrist symptom/complaint

3.0

219.1

1224

2196

J01MA12

ATC

levofloxacin; systemic

2.1

218.6

2733

7292

ZXD20

NOMESCO Finland

Day surgery

2.6

217.8

1638

3474

Z01.8

ICD-10 Finland

Other specified special examinations

2.0

217.1

3100

8700

H02AB07

ATC

prednisone; oral

2.4

217.0

1976

4602

H02AB04

ATC

methylprednisolone; systemic

2.4

216.5

2009

4720

SPAT1212

SPAT

Extensive examination of musculoskeletal system

3.3

212.6

1037

1705

S43.4

ICD-10 Finland

Sprain and strain of shoulder joint

5.6

210.2

537

510

R07.3

ICD-10 Finland

Other chest pain

2.8

209.5

1323

2551

N04BC05

ATC

pramipexole; oral

3.4

209.2

948

1482

ACC59

NOMESCO Finland

Decompression and freeing of adhesions of peripheral nerve: other or unspecified

6.1

208.9

493

428

R06AE09

ATC

levocetirizine; oral

2.4

208.2

1839

4218

P06

ICPC

Sleep disturbance

2.5

206.8

1648

3596

NGF35

NOMESCO Finland

Plastic operation of joint cartilage of knee

10.1

206.6

343

180

A03CA02

ATC

clidinium and psycholeptics; oral

4.1

206.0

747

986

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

1.8

205.9

4169

13157

SFA30

NOMESCO Finland

Three-surface restoration

1.7

204.4

5500

18889

EMB10

NOMESCO Finland

Tonsillectomy

3.9

201.3

768

1056

M16

ICD-10 Finland

Coxarthrosis [arthrosis of hip]

5.6

201.2

515

490

J01MA06

ATC

norfloxacin; oral

2.5

200.8

1685

3769

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.8

199.9

3873

12037

M22.4

ICD-10 Finland

Chondromalacia patellae

7.9

199.2

384

256

D07AD01

ATC

clobetasol; topical

2.3

199.1

2001

4863

S83.6

ICD-10 Finland

Sprain and strain of other and unspecified parts of knee

4.2

197.7

684

868

Z2221

NOMESCO Finland

Medical doctor

1.8

197.5

4088

12965

J01

ICD-10 Finland

Acute sinusitis

4.1

197.2

714

941

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.7

195.9

1375

2807

J02AC02

ATC

itraconazole; systemic

2.2

193.8

2029

5016

M47.9

ICD-10 Finland

Spondylosis, unspecified

7.6

192.2

382

266

R06AX13

ATC

loratadine; oral

2.2

192.0

1986

4883

OAB43, ,

SPAT

1.8

191.6

3918

12363

B01AX06

ATC

[U] rivaroxaban

14.8

190.4

262

SFA10

NOMESCO Finland

One-surface restoration

1.6

190.3

7968

30593

J35.0

ICD-10 Finland

Chronic tonsillitis

4.0

189.9

698

931

S13.4

ICD-10 Finland

Sprain and strain of cervical spine

4.6

189.6

591

684

SHB00

NOMESCO Finland

Preparing and fitting the occlusal splint in the mouth

2.7

188.6

1248

2466

R03BA02

ATC

budesonide; inhalant

2.1

188.4

2415

6478

SFC01

NOMESCO Finland

Additional procedure necessary for restorative treatment

1.9

188.0

3491

10676

R01AD01

ATC

beclometasone; nasal

2.3

187.4

1868

4517

M10.9

ICD-10 Finland

Gout, unspecified

3.1

187.4

991

1715

L88

ICPC

Rheumatoid/seropositive arthritis

6.4

187.2

426

354

J01EA01

ATC

trimethoprim; systemic

1.8

186.9

3608

11170

ZXM10

NOMESCO Finland

Intraoperative use of conventional X-ray imaging

3.8

186.6

742

1053

R5140

NOMESCO Finland

Monitoring the use of the aid

2.6

185.5

1389

2931

WZA00

NOMESCO Finland

Concise certificate

3.4

185.1

870

1393

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

3.2

185.0

937

1577

NBG10

NOMESCO Finland

Acromioplastia

9.4

184.8

319

179

M19.8

ICD-10 Finland

Other specified arthrosis

6.3

183.9

424

358

M43.1

ICD-10 Finland

Spondylolisthesis

6.6

181.7

400

319

Z01.2

ICD-10 Finland

Dental examination

1.6

181.6

6319

23086

NBA30

NOMESCO Finland

Exploration of joint of shoulder or upper arm, arthroscopic

9.0

181.5

322

189

OAB93, ,

SPAT

3.8

180.8

723

1030

M19.1

ICD-10 Finland

Post-traumatic arthrosis of other joints

9.5

179.9

309

172

R21

ICPC

Throat symptom/complaint

1.9

179.8

3141

9399

G03BA03

ATC

testosterone; systemic, rectal, sublingual, transdermal

3.3

179.3

881

1453

C07AB07

ATC

bisoprolol; oral

1.6

178.9

7127

26903

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

3.3

178.5

852

1378

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic

1.7

178.5

4839

16532

U07.2

ICD-10 Finland

COVID-19, virus not identified

1.9

177.7

2924

8573

R05DA01

ATC

ethylmorphine; oral

3.0

177.7

997

1789

G43.3

ICD-10 Finland

Complicated migraine

16.9

177.5

232

S22.3

ICD-10 Finland

Fracture of rib

3.1

177.2

944

1640

L29

ICPC

Musculoskeletal sympt/complt other

2.9

176.8

1069

2005

M19.9

ICD-10 Finland

Arthrosis, unspecified

5.8

176.7

436

398

E66.8

ICD-10 Finland

Other obesity

3.9

176.7

675

928

UJF32

NOMESCO Finland

Coloscopy

1.8

176.3

3443

10674

NAG40

NOMESCO Finland

Anterior fusion of cervical spine without fixation

12.2

175.9

264

114

H04.10

ICD-10 Finland

Dry eye syndrome

2.6

174.7

1305

2748

R02

ICPC

Shortness of breath/dyspnoea

2.2

174.5

1783

4352

K02.1

ICD-10 Finland

Caries of dentine

1.6

173.8

8779

34986

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

15.6

172.2

232

M65.9

ICD-10 Finland

Synovitis and tenosynovitis, unspecified

7.2

172.2

355

260

M75.2

ICD-10 Finland

Bicipital tendinitis

9.1

171.6

302

175

Z71.8

ICD-10 Finland

Other specified counselling

1.7

171.5

4384

14708

C10AA07

ATC

rosuvastatin; oral

1.8

171.4

3628

11519

N06AB03

ATC

fluoxetine; oral

2.3

170.8

1576

3674

NE1BG

NOMESCO Finland

Pelvic, hip and femur MRI examination with high intensity magnet

7.6

170.6

339

236

NBF25

NOMESCO Finland

Operation for humeroscapular osteochondritis, arthroscopic

11.8

170.3

259

115

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.3

170.3

1605

3778

M06.0

ICD-10 Finland

Seronegative rheumatoid arthritis

8.4

169.6

314

197

N05CD07

ATC

temazepam; oral

2.2

169.2

1818

4530

KMAK, ,

NOMESCO Finland

1.6

168.9

7401

28467

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.9

168.5

2785

8164

ABC56

NOMESCO Finland

Decompression of lumbar spinal canal and nerve roots

9.0

167.9

298

175

7151F

ICD-9 Finland

Osteo-arthrosis and allied disorders, Osteo-arthrosis, localised, primary[OSTEOARTHROSIS PRIMARIA, POLVI]

6.4

167.4

378

311

Z3231

NOMESCO Finland

Registered nurse

1.7

167.4

4018

13227

S06.0

ICD-10 Finland

Concussion

2.3

167.1

1576

3710

NG2AA

NOMESCO Finland

Patella X-ray examination

8.0

166.0

318

210

NAG62

NOMESCO Finland

Posterior fusion of lumbar spine with fixation, 2-3 vertebraea

19.1

166.0

208

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

4.6

165.7

515

594

SHA01

NOMESCO Finland

Stomatognathic treatment, simple

2.5

165.3

1270

2710

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

14.5

165.0

229

N06AA10

ATC

nortriptyline; systemic

11.7

164.9

252

113

R4110, ,

SPAT

2.9

164.7

959

1758

ABC26

NOMESCO Finland

Open discectomy of lumbar spine

13.7

164.4

234

L04AA13

ATC

[U] leflunomide

11.4

164.2

255

118

H01

ICPC

Ear pain/earache

2.3

163.8

1549

3649

R06.5

ICD-10 Finland

Mouth breathing

2.8

162.9

1057

2062

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.9

161.3

2531

7279

NA3AA, ,

SPAT

6.6

161.1

357

287

R03AC03

ATC

terbutaline; inhalant

2.1

160.9

1830

4664

M75.8

ICD-10 Finland

Other shoulder lesions

5.1

160.4

444

458

S40.0

ICD-10 Finland

Contusion of shoulder and upper arm

3.9

160.3

611

838

R12

ICD-10 Finland

Heartburn

2.8

160.0

996

1898

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.9

158.2

2647

7777

R60.0

ICD-10 Finland

Localized oedema

2.3

157.7

1584

3830

N40

ICD-10 Finland

Hyperplasia of prostate

1.8

157.6

3469

11109

G54.0

ICD-10 Finland

Brachial plexus disorders

7.5

157.5

316

223

M20.1

ICD-10 Finland

Hallux valgus (acquired)

3.3

157.3

756

1227

R20.2

ICD-10 Finland

Paraesthesia of skin

3.0

157.0

886

1593

A02BA04

ATC

nizatidine; systemic

2.7

157.0

1033

2030

N02AJ13

ATC

tramadol and paracetamol; systemic

9.6

156.4

267

147

3007

Kela drug reimbursment

Erenumab and fremanezumab

32.0

156.0

171

L03.0

ICD-10 Finland

Cellulitis of finger and toe

2.7

156.0

1092

2219

J31.0

ICD-10 Finland

Chronic rhinitis

2.8

155.4

1006

1959

R35

ICD-10 Finland

Polyuria

2.9

155.0

927

1725

A03FA02

ATC

cisapride; oral, rectal

2.7

154.9

1012

1981

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.7

154.8

3559

11537

L04AB01

ATC

etanercept; parenteral

19.7

154.8

192

H92.0

ICD-10 Finland

Otalgia

3.2

154.8

769

1276

F32.9

ICD-10 Finland

Depressive episode, unspecified

2.1

154.2

1843

4787

E66

ICD-10 Finland

Obesity

3.7

154.2

614

871

NG1BG, ,

SPAT

4.8

154.0

453

496

R01AD11

ATC

triamcinolone; nasal

2.7

153.9

1034

2055

D06

ICPC

Abdominal pain localized other

2.6

153.8

1124

2336

NA1AA

NOMESCO Finland

Cervical spine X-ray examination without contrast

5.4

153.7

407

401

NGF00

NOMESCO Finland

Excision of plica of synovy of knee

10.1

153.5

253

131

J01MA01

ATC

ofloxacin; systemic

2.6

153.1

1156

2443

M77.9

ICD-10 Finland

Enthesopathy, unspecified

5.6

153.0

387

363

ZXA10

NOMESCO Finland

Bilateral

1.9

151.7

2460

7144

NB1AA, ,

SPAT

6.0

150.9

362

320

M77.0

ICD-10 Finland

Medial epicondylitis

8.6

150.6

275

169

M65.4

ICD-10 Finland

Radial styloid tenosynovitis [de Quervain]

6.5

150.5

334

269

M01AE51

ATC

ibuprofen, combinations; systemic

18.0

150.1

192

SPAT1283

SPAT

Restricted health certificate

1.9

149.8

2529

7441

WZA90

NOMESCO Finland

Other medical or dental certificate

1.8

149.4

3051

9537

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

149.4

9898

41337

J01CA08

ATC

pivmecillinam; oral

1.6

148.2

5038

18094

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

2.0

147.9

2040

5592

SGA01

NOMESCO Finland

Emergency treatment

2.0

147.8

2079

5739

G56.2

ICD-10 Finland

Lesion of ulnar nerve

5.3

147.1

397

399

R03AK06

ATC

salmeterol and fluticasone; inhalant

2.0

146.9

1963

5317

A06AD11

ATC

lactulose; oral

1.9

146.8

2346

6773

M65.3

ICD-10 Finland

Trigger finger

4.5

146.4

470

558

NB1CG

NOMESCO Finland

Shoulder and humerus extensive MRI examination with high intensity magnet

10.6

146.4

235

116

A06AC51

ATC

ispaghula, combinations; oral

3.7

146.2

593

853

S30.0

ICD-10 Finland

Contusion of lower back and pelvis

3.8

146.2

573

803

NE1AA

NOMESCO Finland

Pelvis X-ray examination

2.8

145.5

905

1722

G04BD08

ATC

solifenacin; oral

3.0

144.5

797

1412

K08.80

ICD-10 Finland

Toothache NOS

2.6

144.4

1059

2203

NHU20

NOMESCO Finland

Removal of internal fixation device from ankle or foot

4.9

144.2

417

449

D07CC01

ATC

betamethasone and antibiotics; topical

2.2

144.1

1589

3991

G03CA03

ATC

estradiol; nasal, systemic, rectal, transdermal, vaginal

1.7

143.6

3850

12991

M05.9

ICD-10 Finland

Seropositive rheumatoid arthritis, unspecified

9.4

143.4

247

138

C10AA05

ATC

atorvastatin; oral

1.6

143.1

5327

19523

J01DC02

ATC

cefuroxime; systemic

3.3

142.9

669

1066

M10.0

ICD-10 Finland

Idiopathic gout

4.1

142.0

506

657

WX111

NOMESCO Finland

Local infiltration anesthesia

6.8

142.0

304

234

NBG00

NOMESCO Finland

Plastic operation on acromioclavicular joint

19.3

141.7

177

M67.4

ICD-10 Finland

Ganglion

3.0

141.7

780

1380

L05

ICPC

Flank/axilla symptom/complaint

3.1

141.7

756

1312

D07CA01

ATC

hydrocortisone and antibiotics; topical

2.1

141.5

1665

4291

UKC02

NOMESCO Finland

Cystoscopy

1.9

141.5

2372

6953

K07.60

ICD-10 Finland

Snapping jaw

3.6

141.2

602

898

SPAT1263

SPAT

Sampling

1.5

141.0

6126

23248

ND2AA, ,

SPAT

4.1

140.9

497

640

XKD00

NOMESCO Finland

Uroflowmetry

1.9

140.5

2350

6883

A11

ICPC

Chest pain NOS

2.6

140.4

986

2005

J45

ICD-10 Finland

Asthma

2.4

138.6

1236

2828

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

2.2

138.5

1413

3432

R03BA08

ATC

ciclesonide; inhalant

2.6

138.5

985

2016

R03BA01

ATC

beclometasone; inhalant

2.0

138.4

1804

4835

ZXD05

NOMESCO Finland

Urgent procedure

1.6

138.4

4543

16127

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

2.0

138.3

1942

5350

N17

ICPC

Vertigo/dizziness

2.1

138.0

1554

3934

B01AF01

ATC

rivaroxaban; oral

2.2

137.9

1422

3470

M17.3

ICD-10 Finland

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3013115) Eosinophils [#/volume] in Blood

8371

29465

1.86

323.31

5.9

6.8

0.20

0.19

e9/l

4.68

7330

25780

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

10587

40251

1.84

319.35

3.3

2.7

47.74

45.74

u/l

1.20

9919

37566

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

8173

28691

1.85

315.90

5.5

6.4

11.17

12.49

umol/l

16.49

7684

27159

(3006315) Basophils [#/volume] in Blood

8108

28535

1.84

308.63

5.8

6.3

0.04

e9/l

2.45

6978

24671

(3013707) Erythrocyte sedimentation rate by Westergren method

11784

38726

2.57

307.65

4.4

3.3

11.49

13.07

mm/h

22.16

10931

35314

(3031040) Bacteria [#/volume] in Urine by Automated count

10632

39172

1.95

307.65

5.0

4.1

1045.92

1472.87

e6/l

0.37

156

669

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

14121

56745

2.20

307.65

14.3

13.0

84.10

81.86

ml/min/173m2

20.02

11961

44527

(3023103) Potassium [Moles/volume] in Serum or Plasma

15167

63263

2.31

307.65

17.5

16.4

3.98

3.96

mmol/l

6.15

14773

60853

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

11572

44893

1.89

307.65

4.0

3.5

14.71

14.82

pmol/l

4.43

10519

40226

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

2968

4478

3.90

307.65

1.3

1.2

11.98

12.13

u/ml

0.02

1131

1565

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

13708

55726

2.04

307.65

4.9

4.0

1.84

2.29

mu/l

5.23

12577

50796

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

11860

43308

2.16

307.65

7.3

7.6

77.32

80.44

u/l

6.60

11143

40623

(3019550) Sodium [Moles/volume] in Serum or Plasma

15130

63094

2.30

307.65

17.4

16.3

139.57

139.52

mmol/l

1.75

14776

60812

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

3173

5044

3.73

307.65

1.3

1.2

28.33

37.06

iu/ml

1.00

933

1532

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

3887

9970

2.29

307.65

1.7

2.1

1.14

1.69

mg/l

9.77

2925

7638

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

15365

61070

2.74

307.65

16.0

13.5

23.26

27.04

mg/l

30.52

12758

46040

(3013650) Neutrophils [#/volume] in Blood by Automated count

9195

33114

1.87

307.65

8.1

10.5

4.25

4.27

e9/l

0.28

7942

28858

(3020564) Creatinine [Moles/volume] in Serum or Plasma

15631

67432

2.25

307.65

17.5

15.4

79.68

82.00

umol/l

12.08

15624

67383

(3026493) Urate [Moles/volume] in Serum or Plasma

4664

11577

2.45

307.65

2.6

3.1

3938.82

5775.73

umol/l

1.92

4046

10262

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

13341

53835

2.01

307.65

5.7

5.2

39.61

39.72

mmol/mol

0.55

12360

49553

(3037467) Urinalysis macro (dipstick) panel - Urine

11123

40750

2.03

307.65

4.6

4.0

—

(3001604) Monocytes [#/volume] in Blood

8082

28476

1.84

305.57

5.8

6.3

0.60

e9/l

0.37

6956

24615

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

15637

68329

2.16

302.45

10.7

8.7

27.46

25.90

u/l

8.17

15123

65346

(3044889) 12 lead EKG panel

10232

38902

1.81

300.76

3.7

—

(40760892) CBC W Ordered Manual Differential panel - Blood

7662

26655

1.84

299.92

6.3

7.0

—

(3019198) Lymphocytes [#/volume] in Blood

8314

29680

1.82

299.51

5.9

6.3

1.92

1.87

e9/l

2.44

7357

26185

(3018010) Neutrophils/100 leukocytes in Blood

7913

27931

1.82

293.88

5.8

6.3

57.42

58.37

9.44

7377

26182

(3019069) Monocytes/100 leukocytes in Blood

7799

27418

1.82

293.23

6.3

6.8

8.52

8.65

2.72

7249

25649

(3002030) Lymphocytes/100 leukocytes in Blood

8026

28502

1.81

291.57

6.0

6.5

27.76

26.88

9.34

7473

26756

(3006504) Eosinophils/100 leukocytes in Blood

7744

27293

1.81

286.92

6.0

6.5

2.84

2.75

2.51

7191

25523

(3013826) Glucose [Moles/volume] in Serum or Plasma

9281

34721

1.77

279.56

4.5

5.3

6.69

6.86

mmol/l

9.29

8725

31525

(3022096) Basophils/100 leukocytes in Blood

7524

26462

1.80

278.12

6.0

6.5

0.65

0.63

1.45

6963

24693

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

13900

58859

1.89

276.12

4.6

3.9

5.93

5.90

mmol/l

1.67

12661

53450

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

6100

20156

1.85

274.57

3.9

3.7

45.05

77.32

ng/l

3.28

3985

14543

(3008898) HLA-B27 [Presence]

815

905

4.84

274.17

1.1

1.0

—

(40768797) Stomach Pathology biopsy report

2404

5559

2.43

271.57

1.2

—

(40761511) CBC panel - Blood by Automated count

15341

67398

2.02

268.38

14.5

12.7

—

(3009261) Glucose [Presence] in Urine by Test strip

7957

28792

1.76

262.84

3.7

3.5

0.00

estimate

0.97

1530

5373

(3018095) Leukocytes [#/volume] in Urine

6098

20388

1.82

261.58

4.0

85.12

133.65

e6/l

2.80

4337

14514

(3035350) Ketones [Presence] in Urine by Test strip

7887

28584

1.75

257.43

3.7

3.4

0.00

estimate

1.99

1638

5952

(3021601) Nitrite [Presence] in Urine by Test strip

7864

28512

1.75

255.82

5.1

4.7

0.00

estimate

0.50

1581

5542

(3037522) Nuclear Ab [Titer] in Serum

2366

5600

2.37

253.19

1.3

491.07

545.05

titre

0.61

459

1140

(40768804) Tissue Pathology biopsy report

6131

20743

1.80

250.61

2.1

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2082

4669

2.48

249.34

1.6

1.3

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

3467

9714

2.05

247.20

1.8

1.5

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

5191

16753

1.84

245.96

2.7

71.35

64.21

u/l

0.18

4779

15546

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

7470

26909

1.74

245.44

2.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

14360

62280

1.86

245.40

4.7

4.1

2.70

2.71

mmol/l

0.26

13249

57468

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

14086

61043

1.81

233.79

4.3

3.8

4.56

4.57

mmol/l

0.56

13110

56653

(36304419) Bacteria [Presence] in Urine

4782

15244

1.84

233.30

3.3

3.4

—

(3044640) Blood type and Crossmatch panel - Blood

5283

17377

1.81

233.25

2.4

2.5

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

4876

15667

1.83

231.79

2.2

197.90

267.11

u/l

4.68

4578

14699

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

13540

58056

1.77

231.34

3.8

3.4

1.34

1.23

mmol/l

49.80

12422

53390

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

13965

60488

1.79

229.25

4.2

3.7

1.39

1.44

mmol/l

30.16

12909

55964

(3002582) Erythrocytes [#/volume] in Urine

5316

17657

1.79

225.92

3.4

3.6

91.71

123.58

e6/l

0.63

4080

13714

(3015736) pH of Urine

6477

22830

1.72

224.19

3.4

3.2

5.95

0.06

599

1241

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

6506

23088

1.71

218.38

2.1

1.9

94.90

92.80

pmol/l

2.57

3402

12708

(3030467) Casts [#/volume] in Urine by Automated count

4853

15837

1.80

216.96

3.3

3.5

0.39

0.50

e6/l

2.23

3703

12201

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

6908

25064

1.68

212.26

5.3

7.4

1.21

mmol/l

9.25

6267

22893

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

7576

28304

1.66

206.92

5.9

8.3

1.21

mmol/l

5.25

6379

23827

(3022217) INR in Platelet poor plasma by Coagulation assay

7391

27543

1.65

202.52

13.6

21.6

1.24

1.43

inr

47.76

2231

8210

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

4055

12757

1.83

201.64

2.3

2.5

—

(3009542) Hematocrit [Volume Fraction] of Blood

16221

74687

1.98

197.12

23.0

19.1

40.57

40.38

0.25

15445

68144

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

10390

42374

1.62

196.48

3.6

2.9

—

(3007461) Platelets [#/volume] in Blood

16227

74801

1.97

194.42

23.0

19.0

250.34

246.51

e9/l

10.51

15865

71927

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

6282

22665

1.66

192.12

2.2

2.3

75.48

74.58

nmol/l

1.52

5608

20471

(3010813) Leukocytes [#/volume] in Blood

16241

74960

1.96

191.88

23.0

18.9

6.93

6.80

e9/l

9.46

15828

71820

(3035941) MCH [Entitic mass]

16234

74936

1.96

191.20

22.8

18.8

30.33

30.13

35.71

16026

73320

(3024731) MCV [Entitic volume]

16235

74955

1.96

190.76

22.9

18.9

90.97

90.39

46.06

16029

73334

(3026361) Erythrocytes [#/volume] in Blood

16236

74963

1.96

190.69

23.0

18.9

4.50

4.51

e12/l

0.08

15811

71858

(3000963) Hemoglobin [Mass/volume] in Blood

16238

75015

1.95

189.31

23.1

19.0

135.79

135.02

g/l

7.94

16029

73418

(3001122) Ferritin [Mass/volume] in Serum or Plasma

7226

27257

1.61

183.21

2.9

3.0

117.44

129.31

ug/l

2.70

6657

25272

(3000850) Epithelial cells [#/volume] in Urine

3805

12084

1.80

180.86

2.7

3.0

5.47

5.42

e6/l

0.08

3388

10840

(3015377) Calcium [Moles/volume] in Serum or Plasma

5121

17755

1.69

179.10

2.9

3.6

2.35

2.34

mmol/l

2.15

4426

15592

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

3703

11722

1.80

177.44

1.3

1.70

2.14

u/ml

0.87

976

3042

(3007164) IgA [Mass/volume] in Serum or Plasma

3322

10202

1.84

175.12

1.5

2.34

2.44

g/l

1.65

2035

6336

(3000492) Spirometry study

1814

4503

2.21

170.43

1.5

1.4

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5633

20464

1.61

160.90

5.1

4.5

2.88

5.06

ug/l

4.02

5002

18131

(3021788) Differential panel - Synovial fluid

418

416

5.31

156.37

1.6

1.4

—

(3033658) Prothrombin time (PT) actual/Normal

4139

14006

1.69

154.37

4.0

4.5

89.89

84.45

30.84

4033

13666

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3392

10928

1.75

150.14

3.2

2.9

0.77

0.89

ug/l

5.56

2226

7488

(3024561) Albumin [Mass/volume] in Serum or Plasma

6551

25006

1.55

149.11

4.4

5.8

35.61

34.84

g/l

19.65

6039

23177

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

4521

15790

1.64

148.70

3.0

3.4

1592.57

2251.80

ng/l

11.42

3772

13862

(3013512) EKG study

4442

15447

1.65

148.55

3.9

4.0

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

545

744

3.89

143.75

1.5

1.3

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

5945

22371

1.56

142.41

3.9

3.6

—

(3048689) Calprotectin [Mass/mass] in Stool

2213

6351

1.92

140.51

2.3

3.1

131.39

159.11

ug/g

2.38

1763

5123

(40758558) Short blood count panel - Blood

4064

14030

1.64

138.22

6.1

7.9

—

(3002385) Erythrocyte distribution width [Ratio]

12817

57081

1.53

136.77

18.1

16.6

14.86

14.74

0.33

12591

55678

(3000475) Leukocytes [#/volume] in Synovial fluid

466

583

4.23

136.68

1.8

1.5

15336.60

13307.97

e6/l

0.35

332

425

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4434

15812

1.60

131.39

4.3

4.0

21.74

22.44

1.99

2063

7961

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1192

2762

2.32

129.79

2.4

2.3

20.44

21.42

au/ml

0.12

197

(1002224) Polysomnography panel

766

1417

2.88

129.09

1.1

1.0

—

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

2942

9473

1.73

128.27

2.9

3.0

1.09

1.19

e6/l

0.49

1564

5529

(3041096) Erythrocytes [Presence] in Urine by Automated

4486

16160

1.58

126.65

3.4

3.3

—

(3042936) Bacteria identified in Isolate by Culture

2441

7563

1.78

120.76

2.0

2.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1084

2489

2.34

120.19

1.3

53.39

59.90

au/ml

0.30

115

(3023368) Bacteria identified in Blood by Culture

4516

16463

1.56

120.02

4.3

4.6

—

(3021589) Normoblasts [#/volume] in Blood

6835

27270

1.48

118.66

9.5

10.0

0.00

e9/l

1.07

5499

22405

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

2836

9226

1.70

118.26

3.1

2.33

2.56

e6/l

0.58

1458

5300

(3026782) Osmolality of Urine

3583

12479

1.61

114.63

2.9

3.3

548.83

544.93

mosm/kgh2o

0.44

3062

10790

(3011397) Hemoglobin [Presence] in Urine by Test strip

3633

12752

1.59

112.26

3.6

3.3

—

(3021960) Folate [Moles/volume] in Serum or Plasma

3703

13069

1.59

111.79

1.6

1.5

19.60

19.31

nmol/l

0.53

3181

11466

(3007853) Bacteria identified in Skin by Aerobe culture

2061

6238

1.80

109.33

1.7

1.8

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

3197

10940

1.62

109.15

3.8

3.7

199.92

674.17

ng/l

17.91

2417

8795

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

2817

9335

1.67

108.87

2.7

3.2

2.44

2.45

mmol/l

2.42

2373

8053

(3026470) Cobalt [Mass/volume] in Blood

141

16.75

107.66

1.9

1.6

4.12

1.94

ug/l

1.79

128

(3026008) Bacteria identified in Urine by Culture

4855

18380

1.50

106.21

3.1

2.9

—

(3018418) pH of Serum or Plasma

4504

16821

1.51

104.81

3.7

5.3

7.40

1.25

855

3350

(3001019) Free T4 and TSH panel - Serum or Plasma

910

2052

2.37

104.65

1.6

1.5

—

(3025577) Chromium [Mass/volume] in Blood

137

16.65

104.38

2.0

1.6

2.36

1.65

ug/l

0.95

114

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

4254

15724

1.52

103.67

2.3

2.96

2.99

mg/l

0.25

3574

13403

(3019225) pH of Specimen

1635

4686

1.89

102.41

4.0

5.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

1687

4900

1.87

101.45

2.5

2.7

33.99

38.85

u/l

0.90

1432

4237

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

5182

20036

1.47

101.28

3.1

3.2

35.59

34.19

u/l

0.18

4880

18941

(3009508) Creatinine [Moles/volume] in Urine

4800

18287

1.49

100.84

3.2

3.5

7.96

7.62

mmol/l

4.40

3979

15627

(3002256) Pathology report gross observation

2059

6428

1.74

97.81

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

2517

8309

1.66

97.74

2.4

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

2739

9272

1.63

96.37

2.5

2.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1494

4245

1.90

95.75

2.3

1.9

12.26

11.86

nmol/l

0.86

1323

3803

(3000494) Fungus identified in Specimen by Culture

1867

5749

1.76

92.65

1.4

1.5

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1113

2886

2.07

91.80

1.2

—

(3003338) MCHC [Mass/volume]

12601

57742

1.41

90.76

19.4

16.7

332.72

332.66

g/l

0.26

12495

57000

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2274

7453

1.66

90.17

1.9

1.7

1.43

0.09

1982

6608

(3022145) Colonoscopy Study observation

1768

5399

1.77

90.09

1.3

1.5

—

(3017732) Neutrophils [#/volume] in Blood

1224

3324

1.98

89.10

2.6

3.5

5.17

5.28

e9/l

0.08

997

2658

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1865

5815

1.74

88.46

4.4

4.2

31.42

32.83

5.57

1317

3989

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1570

4648

1.82

88.42

2.0

2.2

369.62

400.98

nmol/l

5.60

1428

4289

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

270

310

4.57

87.27

1.7

1.5

58.11

62.91

0.78

170

209

(3002523) Influenza virus A Ag [Presence] in Specimen

377

571

3.48

86.47

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

377

572

3.47

86.26

1.1

—

(3044941) Cell count panel - Synovial fluid

302

402

3.95

82.18

1.5

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

1944

6267

1.68

81.45

2.8

2.9

7.53

10.23

umol/l

6.55

1672

5441

(3019309) Folate [Moles/volume] in Red Blood Cells

3103

11245

1.52

79.97

1.8

1.7

1138.50

1163.11

nmol/l

0.68

2285

8485

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

984

2600

2.02

76.93

1.1

1.0

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

694

1590

2.31

76.81

1.6

1.7

—

(3025941) Bacteria identified in Stool by Culture

1078

2951

1.95

76.44

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

3738

14208

1.46

75.76

1.6

1.41

1.33

mmol/l

5.61

3123

12132

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2725

9731

1.53

74.60

1.9

—

(3012516) Albumin [Mass/volume] in Urine

4216

16433

1.43

74.59

3.2

3.7

235.21

409.11

mg/l

2.32

2753

11149

(36660697) Celiac disease serology panel - Serum

1351

4019

1.80

74.43

1.2

1.1

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

642

1447

2.35

73.62

1.2

0.57

1.27

u/ml

0.69

110

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

486

966

2.65

71.78

1.2

1.3

10.53

45.91

u/ml

2.78

(3029937) Albumin [Presence] in Urine by Test strip

3997

15521

1.43

71.72

4.1

3.6

0.00

estimate

0.43

1521

5137

(3020682) Albumin/Creatinine [Ratio] in Urine

4440

17583

1.41

71.34

3.9

4.3

10.25

12.68

mg/mmol

2.14

2837

11972

(4200892) Spirometry reversibility

1067

2993

1.90

70.38

1.4

1.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

1041

2908

1.91

69.49

1.3

180.24

361.75

u/ml

5.62

954

2680

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

451

891

2.67

67.37

1.2

1.3

6.36

9.82

u/ml

0.55

135

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

446

877

2.68

67.20

1.2

1.3

3.45

10.56

u/ml

0.65

(1761868) Lipid panel - Serum or Plasma

5162

21216

1.36

65.23

2.7

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

444

893

2.62

64.14

2.0

1.6

205.74

189.53

pmol/l

1.62

419

847

(3020961) Endomysium IgA Ab [Titer] in Serum

853

2292

1.98

63.52

1.1

226.71

228.71

titre

0.01

(3024891) Influenza virus A+B Ag [Presence] in Specimen

570

1312

2.29

62.37

1.2

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

622

1498

2.20

61.31

1.9

1.5

38.55

45.15

nmol/l

7.80

605

1472

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

723

1925

1.99

55.14

3.6

4.8

24.63

24.52

mmol/l

0.38

664

1751

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

497

1149

2.28

53.84

1.6

2.0

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

3167

12392

1.39

52.10

1.7

21026657.56

29734904.64

pmol/l

0.44

2592

10244

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1709

5930

1.55

51.90

3.5

3.7

—

(40761536) Microorganisms panel - Urine sediment

1533

5190

1.58

51.77

3.9

4.0

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

363

737

2.59

51.54

1.2

1.3

55.37

37.60

u/ml

0.66

(3045414) Leukocytes [Presence] in Urine

774

2164

1.89

51.31

1.9

—

(3019150) Specific gravity of Urine by Refractometry

3273

12916

1.38

51.07

4.0

3.5

1.02

kg/l

1.03

540

2300

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

457

1044

2.30

50.86

1.2

1.1

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

479

1125

2.24

50.07

1.4

1.3

—

(4094501) Cardiovascular stress test using bicycle ergometer

419

928

2.37

49.89

1.1

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

773

2189

1.87

49.30

2.0

1.9

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

688

1884

1.93

48.45

2.1

1.7

—

(3004588) Protein electrophoresis panel - Serum or Plasma

1100

3485

1.68

48.16

2.1

2.3

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

854

2515

1.80

48.16

2.5

2.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

1225

3994

1.63

48.08

2.3

2.8

10.26

10.95

g/l

6.45

1097

3666

(3003327) Ova and parasites identified in Stool by Light microscopy

636

1710

1.96

47.17

1.7

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1132

3642

1.65

46.75

3.4

4.1

5.13

5.12

kpa

0.18

1070

3439

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

177

242

3.82

46.74

1.5

1.4

31.59

26.93

0.66

102

168

(40768443) Skin Pathology biopsy report

723

2042

1.87

46.47

1.2

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

353

746

2.48

46.35

1.2

1.3

3.01

8.73

u/ml

0.75

(3009343) pH of Capillary blood

1122

3612

1.65

46.22

3.4

4.1

7.41

7.42

1.04

130

567

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

710

2003

1.87

45.79

1.9

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

548

1422

2.03

44.78

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

546

1415

2.03

44.77

1.2

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

502

1261

2.10

44.62

1.4

274.81

256.30

ug/g

0.99

285

753

(3022313) Gas panel - Capillary blood

802

2373

1.79

44.51

3.6

4.4

—

(3004616) Nuclear Ab [Presence] in Serum

227

384

3.09

44.34

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1089

3516

1.65

44.32

3.4

4.0

1.45

1.71

mmol/l

1.28

780

2525

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

537

1408

2.01

42.68

1.2

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1041

3370

1.64

41.89

1.7

—

(3010144) Erythrocytes [#/volume] in Synovial fluid

167

239

3.65

41.59

1.5

1.4

112237.50

87756.01

e6/l

0.19

123

161

(3023511) Choriogonadotropin [Units/volume] in Urine

534

1414

1.99

41.32

1.5

1.3

—

(21494755) Public health laboratory ask at order entry panel

1637

5901

1.48

41.16

1.3

1.2

—

(40761535) Cells panel - Urine sediment

1188

4003

1.58

40.62

3.5

3.6

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

1347

4682

1.53

40.18

2.3

6.70

9.68

ug/l

4.60

1116

4062

(3020630) Protein [Mass/volume] in Serum or Plasma

1315

4550

1.54

40.04

2.3

2.4

66.43

65.77

g/l

2.16

1193

4141

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

571

1574

1.91

39.44

1.5

1.6

11.14

2.96

iu/ml

0.34

110

401

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

692

2046

1.78

38.47

1.8

2.0

37.79

38.19

u/l

0.19

602

1776

(3022621) pH of Urine by Test strip

1150

3898

1.57

38.29

3.2

2.9

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

289

612

2.47

37.87

1.1

16.37

17.13

au/ml

0.02

(44816559) Phosphatidylethanol [Mass/volume] in Blood

412

1025

2.11

37.56

1.3

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

577

1628

1.87

37.19

2.2

2.4

0.90

0.96

g/l

0.14

505

1387

(3022948) Iron [Moles/volume] in Serum or Plasma

2565

10196

1.35

36.97

2.2

3.1

13.07

12.62

umol/l

2.00

2373

9504

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

625

1813

1.82

36.96

2.1

2.3

2.98

g/l

0.04

563

1619

(3023323) Follitropin [Units/volume] in Serum or Plasma

732

2237

1.73

36.38

1.4

1.3

19.72

22.70

iu/l

1.67

620

1872

(3012095) Magnesium [Moles/volume] in Serum or Plasma

2461

9749

1.36

36.20

2.8

3.9

0.82

mmol/l

0.35

2275

9142

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

531

1476

1.89

35.80

2.1

2.2

38.07

36.88

g/l

3.89

469

1278

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

350

835

2.20

35.36

1.7

1.4

—

(3014111) Lactate [Moles/volume] in Serum or Plasma

1492

5436

1.46

35.34

5.8

8.0

1.40

1.41

mmol/l

0.25

1444

5271

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

662

1985

1.76

35.12

2.1

2.2

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

663

1989

1.76

35.11

2.1

2.2

7.41

7.31

g/l

0.68

599

1796

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

483

1309

1.94

35.06

2.2

0.00

g/l

-0.00

447

1199

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

660

1985

1.75

34.66

2.1

2.2

3.72

3.73

g/l

0.11

599

1795

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1604

5948

1.44

34.62

7.4

—

(3028026) IgM [Mass/volume] in Serum or Plasma

956

3177

1.59

34.54

1.7

1.9

1.23

1.38

g/l

1.45

869

2892

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

519

1450

1.88

34.48

2.1

2.2

0.06

0.03

g/l

0.52

481

1311

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

486

1331

1.92

34.24

2.2

0.00

g/l

0.25

448

1202

(3034891) Synovial lining cells/100 cells in Synovial fluid

104

120

4.52

33.69

1.4

5.21

2.81

0.68

(3014051) Protein [Presence] in Urine by Test strip

478

1325

1.90

32.52

2.7

2.3

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

242

507

2.50

32.47

2.1

2.0

23.93

30.87

mg/l

0.78

119

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

895

2977

1.59

32.19

2.7

2.3

5349.80

8397.74

u/l

1.83

336

1299

(1001926) Buprenorphine [Presence] in Urine by Screen method

803

2603

1.63

32.06

2.4

2.0

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1794

6877

1.39

32.03

1.7

1.8

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

975

3315

1.56

31.94

3.2

3.6

4.49

4.46

pmol/l

0.31

868

2970

(3039443) Prostate specific Ag panel - Serum or Plasma

318

761

2.19

31.94

1.6

1.5

—

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

613

1856

1.74

31.47

2.1

2.2

10.23

10.67

g/l

1.38

550

1648

(3016879) Cocaine [Presence] in Urine

923

3125

1.56

30.78

2.4

1.9

—

(3011288) Drugs identified in Urine by Screen method

702

2223

1.66

30.66

3.5

2.5

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1751

6732

1.39

30.66

1.8

—

(3036670) Protein [Mass/volume] in Synovial fluid

5.49

30.41

1.2

38.84

40.93

g/l

0.40

(3027945) Reticulocytes/100 erythrocytes in Blood

1853

7207

1.37

30.22

2.3

2.8

1.77

1.75

0.37

1610

6365

(3004789) Transferrin [Mass/volume] in Serum or Plasma

2367

9559

1.33

30.20

2.2

3.2

2.32

2.27

g/l

3.72

2158

8875

(3004716) Salmonella sp identified in Stool by Organism specific culture

902

3052

1.56

30.16

1.3

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1083

3816

1.50

30.13

1.2

132.02

146.98

iu/ml

0.36

362

1411

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1792

6935

1.38

30.13

1.8

—

(3002179) Metamyelocytes/100 leukocytes in Blood

1255

4566

1.46

29.80

3.7

4.6

0.56

0.76

1.95

410

1565

(3028707) Methadone [Presence] in Urine by Screen method

483

1384

1.83

29.73

3.1

2.6

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1424

5317

1.42

29.44

1.4

1.5

—

(3052851) Hemolysis interference index of Serum or Plasma

575

1744

1.73

29.35

3.0

3.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

203

411

2.58

29.18

1.3

1.6

22.62

37.05

iu/ml

1.09

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1220

4438

1.46

28.97

1.6

1.8

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

161

288

2.92

28.90

1.2

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

161

289

2.91

28.73

1.2

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

161

289

2.91

28.73

1.2

1.1

—

(3021440) Promyelocytes/100 leukocytes in Blood

1300

4813

1.43

28.11

3.9

4.8

0.09

0.08

403

1603

(3038177) Helicobacter pylori Ab [Presence] in Serum

317

801

2.07

27.89

1.2

—

(3025159) Blasts/100 leukocytes in Blood

1235

4536

1.44

27.87

3.9

4.8

0.36

0.20

0.27

336

1356

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2214

8955

1.32

27.77

2.3

3.3

22.78

22.30

0.75

1929

7538

(3000764) Benzodiazepines [Presence] in Urine

964

3373

1.51

27.70

2.3

1.9

—

(3027008) Opiates [Presence] in Urine

968

3398

1.50

27.39

2.3

1.9

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

157

286

2.87

27.35

1.2

1.1

—

(3028300) Cannabinoids [Presence] in Urine

969

3404

1.50

27.32

2.4

1.9

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

157

288

2.85

27.04

1.2

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

157

288

2.85

27.04

1.2

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

238

543

2.29

26.76

1.2

—

(3027944) Amphetamines [Presence] in Urine

951

3347

1.50

26.57

2.3

1.9

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1482

5672

1.39

26.51

2.2

1.9

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

274

668

2.15

26.40

1.1

2.84

2.82

u/ml

0.01

124

297

(3017143) Hepatitis C virus Ab [Presence] in Serum

2125

8603

1.32

26.40

1.6

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

237

545

2.27

26.19

1.2

1.1

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1420

5414

1.39

25.97

1.7

1.5

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

589

1865

1.66

25.76

1.4

7.95

8.83

u/l

1.03

491

1511

(3017181) Myelocytes/100 leukocytes in Blood

1346

5094

1.40

25.69

3.9

4.7

0.75

0.90

1.32

447

1866

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

137

241

2.97

25.34

1.2

71.43

19.79

u/ml

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

1409

5397

1.38

25.04

2.2

2.4

0.21

0.20

g/l

5.14

1301

4979

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

438

1295

1.77

24.44

1.8

2.1

11.40

12.32

mg/l

0.65

400

1208

(3003888) Timothy IgE Ab [Units/volume] in Serum

354

978

1.90

24.42

1.1

7.99

7.19

u/ml

0.26

176

549

(3049717) Cytology report of Urine Cyto stain

656

2166

1.59

24.33

2.7

2.9

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

383

1095

1.83

23.82

1.1

2.53

2.86

u/ml

0.19

188

611

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

128

226

2.95

23.57

1.2

2.40

27.21

u/ml

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

483

1486

1.71

23.51

1.1

1.93

7.54

u/ml

3.66

168

(3018677) aPTT in Platelet poor plasma by Coagulation assay

2360

9837

1.28

23.38

1.9

2.4

30.03

30.31

1.35

2288

9538

(3008401) Mugwort IgE Ab [Units/volume] in Serum

337

930

1.90

23.35

1.1

1.05

1.28

u/ml

0.27

133

446

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

1152

4315

1.41

23.28

2.5

3.0

69.07

61.20

ml/min/173m2

6.82

445

1806

(3024263) Appearance of Synovial fluid

135

3.59

22.94

1.9

1.3

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

226

541

2.18

22.83

1.3

1.5

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

226

541

2.18

22.83

1.3

1.5

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

232

566

2.14

22.39

1.3

1.5

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

2094

8642

1.29

22.35

1.5

1.4

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

224

540

2.17

22.26

1.3

1.5

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

211

500

2.20

21.85

1.1

1.3

102.17

54.80

u/ml

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

226

555

2.13

21.49

1.3

1.5

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

1803

7337

1.31

21.34

3.7

4.6

237.68

251.27

u/l

1.84

1693

7009

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

224

551

2.12

21.22

1.3

1.5

—

(3035320) C reactive protein [Mass/volume] in Body fluid

157

330

2.48

21.11

2.3

2.2

—

(3023520) Reticulocytes [#/volume] in Blood

1355

5299

1.35

21.08

2.5

2.8

69.48

67.40

e9/l

1.12

983

3998

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

230

575

2.09

20.93

1.1

0.07

0.38

u/ml

1.97

163

(3009445) Proteinase 3 Ab [Units/volume] in Serum

697

2425

1.51

20.58

1.3

1.7

11.65

13.80

u/ml

0.14

(3014133) Dog dander IgE Ab [Units/volume] in Serum

273

734

1.94

20.45

1.1

2.98

4.63

u/ml

1.37

124

396

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

560

1857

1.58

20.45

1.5

1.7

274.55

310.38

titre

0.10

(3003694) ABO and Rh group [Type] in Blood

4412

19948

1.19

20.02

1.5

1.6

—

(3009015) Lactate [Moles/volume] in Synovial fluid

10.40

19.91

1.2

1.1

6.12

6.27

mmol/l

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

258

688

1.96

19.80

1.1

5.94

5.72

u/ml

0.05

325

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

352

1043

1.77

19.59

1.3

1.4

—

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

104

183

2.96

19.35

1.1

1.0

6.69

8.96

iu/ml

0.51

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

402

1243

1.69

19.29

1.2

1.3

514.10

545.29

mg/l

0.43

379

1179

(3010726) Horse dander IgE Ab [Units/volume] in Serum

320

926

1.81

19.25

1.1

2.62

1.96

u/ml

0.48

150

521

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1162

4499

1.36

19.24

2.1

1.9

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

294

829

1.85

19.18

1.6

1.7

0.73

0.83

g/l

0.81

226

631

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

304

867

1.83

19.15

1.7

1.5

—

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

883

3267

1.42

19.10

7.8

10.3

24.09

24.13

mmol/l

0.12

849

3126

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

365

3100

0.60

19.05

1.4

1.7

—

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

619

2139

1.52

18.88

1.1

1.01

6.00

u/ml

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

986

3728

1.39

18.86

6.3

8.6

24.76

24.47

mmol/l

1.49

978

3687

(3010838) Calcium [Moles/time] in 24 hour Urine

278

776

1.87

18.71

1.9

1.8

4.88

4.67

mmol/24h

0.45

242

669

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

111

3.56

18.68

1.1

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

1087

0.36

18.60

15.5

13.9

755.33

2241.84

nmol/l

0.82

1053

(3015183) Erythrocyte sedimentation rate

101

179

2.94

18.59

1.3

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1002

3809

1.39

18.56

1.5

—

(3045424) Erythrocytes [Presence] in Urine

277

775

1.87

18.52

1.5

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

106

197

2.80

18.02

1.4

1.2

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

478

1581

1.58

17.69

1.3

1.6

6.22

9.14

iu/ml

0.73

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

456

1492

1.60

17.65

1.5

1.8

1.18

1.14

g/l

1.91

430

1415

(3037121) Protein [Mass/volume] in Urine

588

2044

1.51

17.47

3.0

3.8

0.35

0.41

g/l

0.61

246

1085

(3021387) Prolactin [Units/volume] in Serum or Plasma

731

2657

1.45

17.41

1.5

1.8

297.10

374.27

mu/l

2.91

651

2363

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

412

1320

1.63

17.35

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

412

1320

1.63

17.35

1.4

1.3

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

103

195

2.75

16.98

3.3

2.2

200.88

151.42

umol/l

0.56

(44813793) Dust mix specific IgE antibody measurement

139

311

2.33

16.52

1.1

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

264

756

1.82

16.49

1.3

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

443

1468

1.58

16.30

1.5

1.8

0.23

g/l

0.20

419

1390

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

978

3784

1.36

16.26

1.4

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

111

3.33

15.93

1.1

1.2

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

350

1101

1.66

15.85

1.2

1.3

3.78

3.90

mmol/l

0.91

327

1032

(3044290) Cell count panel - Cerebral spinal fluid

335

1044

1.68

15.71

1.3

1.4

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1301

5276

1.30

15.67

2.8

3.4

229.55

301.16

ng/l

4.45

1153

4841

(3048929) Epstein Barr virus Ab [Presence] in Serum

626

2270

1.45

15.13

1.2

1.3

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

134

308

2.27

15.05

1.2

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

359

1161

1.62

14.64

1.3

1.2

—

(3026389) Candida sp identified in Specimen by Organism specific culture

237

682

1.81

14.64

1.3

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

489

1701

1.51

14.55

1.7

—

(3027801) Oxygen [Partial pressure] in Arterial blood

1697

7186

1.25

14.38

6.2

7.9

12.06

12.36

kpa

1.36

1613

6823

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

1696

7189

1.25

14.24

6.2

7.9

5.10

5.03

kpa

1.94

1609

6824

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

339

2736

0.64

14.24

1.6

1.7

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

345

1115

1.62

14.13

1.3

1.5

19.32

45.97

e6/l

1.46

259

867

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

241

707

1.78

14.01

1.6

1.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

344

1115

1.61

13.93

1.4

1.5

1117.01

1243.41

e6/l

0.08

272

915

(3024139) IgG subclass 3 [Mass/volume] in Serum

187

506

1.93

13.93

1.5

1.3

0.37

0.44

g/l

1.74

131

343

(4062490) Immunoglobulin typing, IgG

187

506

1.93

13.93

1.6

1.3

—

(3014007) Fractional oxyhemoglobin in Arterial blood

929

3654

1.34

13.89

7.9

10.7

93.58

93.72

0.24

922

3640

(3027135) IgG subclass 1 [Mass/volume] in Serum

187

507

1.92

13.86

1.5

1.3

6.35

7.39

g/l

2.41

131

347

(3028192) IgG subclass 2 [Mass/volume] in Serum

187

507

1.92

13.86

1.5

1.3

2.87

3.16

g/l

1.33

130

347

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

3.65

13.80

1.2

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

157

2.75

13.79

1.1

1.0

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

137

331

2.16

13.75

1.6

82.92

95.39

umol/l

2.36

137

331

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

3.68

13.69

1.0

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

3.68

13.69

1.0

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

3.68

13.69

1.0

1.2

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

109

240

2.37

13.51

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

108

237

2.37

13.48

1.2

1.0

7.53

6.39

nmol/l

0.08

(3000991) Gas panel - Venous blood

1308

5422

1.27

13.27

6.9

9.9

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

149

379

2.05

13.17

1.7

2.2

19.44

19.45

nmol/l

0.01

139

364

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

214

618

1.81

13.13

1.2

1.3

0.19

0.25

nmol/l

0.34

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

291

2384

0.63

13.11

1.4

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

511

1834

1.46

13.08

1.3

—

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

1219

5021

1.28

13.02

3.4

4.7

1.22

mmol/l

0.12

1044

4422

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

931

3699

1.32

13.01

7.7

10.4

1.36

0.05

923

3670

(3016018) Differential panel - Cerebral spinal fluid

184

509

1.89

12.89

1.3

1.5

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

212

614

1.80

12.89

1.2

1.3

0.59

1.71

nmol/l

0.85

203

588

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

132

323

2.13

12.88

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

131

321

2.13

12.74

1.2

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

193

545

1.85

12.72

3.5

3.9

55.31

57.26

0.53

168

443

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

382

1301

1.54

12.59

1.8

1.9

3.75

4.17

iu/l

0.36

139

493

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

825

3237

1.34

12.56

3.1

5.7

24.20

23.82

mmol/l

2.64

802

3133

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

200

2.45

12.54

1.4

1.5

7.27

7.18

u/l

0.02

164

(3042517) Benzodiazepines panel - Urine

3.94

12.46

2.9

2.3

—

(3003396) Base excess in Arterial blood by calculation

1676

7198

1.23

12.43

6.3

7.9

0.79

1.06

mmol/l

1.78

1318

5576

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

925

3699

1.31

12.35

7.9

10.5

0.66

0.67

0.27

915

3675

(3030981) Hyaline casts [#/volume] in Urine by Automated count

849

3356

1.33

12.30

2.9

3.1

0.34

0.33

e6/l

0.03

822

3302

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

595

2223

1.40

12.28

2.9

3.2

45.54

84.75

u/ml

2.36

576

2149

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

576

2145

1.41

12.12

1.7

1.6

3.47

3.93

mg/l

0.46

433

1327

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

598

2245

1.40

12.01

2.1

2.7

793.38

679.00

ug/l

0.13

559

2119

(3010375) cycloSPORINE [Mass/volume] in Blood

673

0.35

11.84

16.7

27.5

122.74

101.93

ug/l

1.47

575

(46235355) HIV 1 and 2 tests - Meaningful Use set

3550

16358

1.16

11.79

2.0

—

(4146454) Self-monitoring of blood glucose

180

510

1.84

11.78

2.5

2.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

499

1821

1.43

11.75

2.9

3.1

42.87

51.99

mg/l

0.34

404

1453

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

142

2.68

11.61

1.7

2.1

1.33

0.86

ug/l

0.92

135

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

1094

4513

1.27

11.55

3.3

5.8

87.50

117.05

ng/l

16.40

931

3933

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

150

403

1.94

11.50

2.0

1.7

—

(3015076) Soybean IgE Ab [Units/volume] in Serum

107

252

2.21

11.49

1.0

0.66

0.55

u/ml

0.18

(3034860) Kappa light chains.free [Mass/volume] in Serum

497

1825

1.42

11.34

2.9

3.1

51.86

64.15

mg/l

1.63

404

1456

(3010421) pH of Blood

478

1748

1.43

11.16

4.3

4.8

7.42

0.15

436

1562

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

189

557

1.77

10.94

3.3

4.4

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

167

474

1.84

10.91

1.0

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

417

1494

1.46

10.85

1.2

1.3

1142.50

922.95

titre

—

(3023410) Appearance of Cerebral spinal fluid

169

484

1.82

10.74

1.4

1.7

—

(3007566) Smooth muscle Ab [Titer] in Serum

425

1533

1.45

10.69

1.2

1.3

83.79

92.08

titre

0.18

149

(3003458) Phosphate [Moles/volume] in Serum or Plasma

1980

8783

1.19

10.46

4.8

8.7

1.04

1.06

mmol/l

2.11

1827

8199

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

162

462

1.83

10.45

1.4

1.3

228.91

189.53

pmol/l

0.31

162

462

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

4.86

10.38

1.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

482

1790

1.41

10.36

2.9

3.0

3.44

5.21

ratio

0.42

144

(3016502) Oxygen saturation in Arterial blood

1476

6382

1.22

10.23

6.5

8.5

95.29

95.32

0.05

1430

6128

(40768446) Kidney Pathology biopsy report

502

0.31

10.23

1.8

1.9

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

188

565

1.73

10.22

1.2

1.3

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

194

589

1.72

10.18

3.9

4.7

—

(4035726) Immunohistochemistry procedure

1124

4729

1.25

10.07

1.3

1.4

—

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

138

2.56

10.05

1.9

2.4

7.98

9.63

mg/l

1.30

111

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

4.08

9.80

1.1

71.45

93.46

ug/l

1.70

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

1353

5825

1.22

9.79

3.5

4.3

21.60

25.26

ug/l

0.19

1060

4799

(3002619) Bacteria identified in Specimen by Culture

2.91

9.49

1.1

1.2

—

(3036180) Methadone [Presence] in Urine

143

407

1.83

9.34

2.1

2.4

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

110

287

2.00

9.24

1.0

0.38

2.82

u/ml

1.36

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

190

2.25

9.24

1.3

1.2

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

5.43

9.17

1.4

1.5

311.39

361.45

umol/24h

0.49

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

138

392

1.83

9.08

1.1

267.59

271.14

mg/l

0.06

121

338

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

136

385

1.84

9.04

1.1

—

(3013290) Carbon dioxide [Partial pressure] in Blood

413

1533

1.41

8.97

4.6

4.8

5.02

4.99

kpa

0.25

403

1492

(3012501) Base excess in Blood by calculation

413

1533

1.41

8.97

4.6

4.8

2.60

2.67

mmol/l

0.16

260

1011

(3036071) Salmonella sp Ab [Titer] in Serum

128

2.52

8.92

1.1

—

(3020874) Milk IgE Ab [Units/volume] in Serum

113

303

1.94

8.83

1.1

1.0

0.90

1.78

u/ml

0.48

(3020491) Glucose [Moles/volume] in Blood

147

430

1.78

8.82

1.7

7.08

6.66

mmol/l

0.62

105

316

(3027315) Oxygen [Partial pressure] in Blood

414

1543

1.40

8.79

4.6

4.9

8.56

8.60

kpa

0.16

404

1501

(3035637) Corticotropin [Mass/volume] in Plasma

190

599

1.65

8.77

1.5

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

218

712

1.60

8.75

1.3

1.4

16.70

21.77

u/l

1.87

177

594

(3050129) First trimester maternal screen panel - Serum or Plasma

578

3898

0.76

8.67

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

272

938

1.51

8.63

1.5

0.45

0.41

nmol/l

0.26

222

786

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

142

414

1.79

8.63

1.2

1.1

38.68

48.19

mg/l

1.87

117

346

(3032057) Clostridioides difficile [Presence] in Stool

2.80

8.57

2.1

1.9

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

103

2.68

8.55

1.6

1.8

123.66

112.39

au/ml

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

306

0.20

8.52

5.2

5.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

414

1555

1.39

8.43

1.4

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

3.24

8.38

1.2

—

(3042733) HLA Ab [Presence] in Serum

483

0.36

8.36

3.9

5.4

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

208

680

1.59

8.34

1.1

1.50

1.54

g/l

0.57

185

624

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

199

2.14

8.34

2.0

2.7

115.19

556.24

ug/l

0.66

179

(40768800) Prostate Pathology biopsy report

340

1236

1.44

8.32

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

178

560

1.66

8.31

2.5

3.3

37.68

7.16

nmol/l

0.49

172

543

(3016244) Insulin [Units/volume] in Serum or Plasma

109

298

1.90

8.10

3.7

2.6

25.92

19.91

mu/l

1.22

103

273

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

104

280

1.93

8.08

1.1

1.06

1.11

u/l

0.25

103

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

117

333

1.83

7.73

1.2

1.3

1.76

1.91

u/ml

0.06

196

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

354

1315

1.41

7.72

3.6

4.1

57.40

58.81

1.30

354

1315

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

509

0.41

7.67

1.7

2.6

136.38

155.32

nmol/l

0.60

439

(3006462) Nitrate [Presence] in Urine

221

2.02

7.61

3.8

2.1

—

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

184

2.12

7.47

1.0

16.30

15.16

u/ml

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

288

1037

1.45

7.46

1.1

—

(3029075) Extractable nuclear Ab panel - Serum

124

2.39

7.45

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

163

520

1.63

7.28

1.1

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

1322

5851

1.19

7.16

7.0

9.0

122.64

120.03

g/l

4.41

1295

5686

(3024928) Oxygen saturation in Venous blood

369

1403

1.37

7.06

2.3

4.1

—

(40767503) Oxygen content in Capillary blood by calculation

374

1428

1.37

6.98

2.4

2.9

16.46

16.18

0.55

191

818

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

511

2044

1.31

6.97

2.6

2.8

—

(3044927) Protein electrophoresis panel - Urine

160

514

1.62

6.97

1.2

—

(3023419) Bacteria identified in Sputum by Culture

240

846

1.48

6.96

2.6

2.7

—

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

2.77

6.95

1.6

1.3

27.46

36.58

0.73

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

2.73

6.94

1.4

1.8

0.42

0.49

ug/l

0.32

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

129

392

1.71

6.91

1.1

1.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

226

1.96

6.90

1.1

—

(3024354) Oxygen [Partial pressure] in Venous blood

1195

5264

1.19

6.84

2.8

3.8

4.59

4.69

kpa

0.63

1141

5056

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

218

1.96

6.68

1.1

1.2

—

(3032773) Endomysium IgG Ab [Titer] in Serum

145

465

1.62

6.40

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

127

2.25

6.38

1.3

1.2

—

(40760548) Muscle specific receptor tyrosine kinase Ab [Units/volume] in Serum by Immunoassay

2.79

6.36

1.1

1.0

—

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

128

399

1.67

6.30

1.0

1.1

292.08

294.65

mg/l

0.10

111

359

(40760888) Immunoglobulin light chains.free panel - Serum

363

1404

1.35

6.29

3.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

296

1108

1.39

6.27

1.1

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

2.51

6.27

2.0

2.3

7.92

7.79

mmol/l

0.04

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

214

1593

0.69

6.21

1.2

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

609

2532

1.26

6.18

1.3

1.5

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

746

3173

1.23

6.17

1.8

2.0

1.49

1.44

g/l

0.80

637

2705

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

297

0.31

6.16

1.1

1.2

—

(3005011) Chlamydia sp Ab [Titer] in Serum

3.06

6.15

1.7

—

(3012544) pH of Venous blood

1473

6662

1.16

6.13

3.2

4.9

7.39

0.02

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

154

2.09

6.07

1.1

1.2

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

260

1.82

6.04

2.7

2.4

—

(3028772) Osteocalcin [Mass/volume] in Serum or Plasma

108

326

1.72

5.99

2.7

3.0

39639.07

41994.17

ug/l

0.84

108

326

(3004809) Band form neutrophils/100 leukocytes in Blood

278

1040

1.39

5.94

3.8

3.6

1.04

1.60

2.41

245

906

(3002032) Base excess in Venous blood by calculation

1428

6462

1.16

5.91

3.2

5.0

1.91

1.69

mmol/l

1.33

1204

5386

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

142

2.12

5.90

1.1

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

108

328

1.71

5.87

1.7

—

(3035933) Granulocytes/100 leukocytes in Blood

116

2.24

5.77

1.5

3.0

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

132

426

1.61

5.73

1.2

1.1

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

128

410

1.62

5.73

1.2

2.06

2.19

mmol/l

0.40

120

377

(3015235) Bicarbonate [Moles/volume] in Capillary blood

445

1798

1.29

5.72

3.1

3.3

24.27

24.44

mmol/l

0.36

437

1755

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

266

995

1.39

5.70

1.5

1.4

199.14

120.32

pmol/l

0.79

259

959

(3020191) Ethanol [Moles/volume] in Serum or Plasma

149

496

1.56

5.70

1.7

1.4

1.51

1.11

promille

2.05

112

389

(3028626) Oxygen [Partial pressure] in Capillary blood

392

1559

1.31

5.66

2.8

3.2

8.13

8.12

kpa

0.07

384

1524

(3021447) Carbon dioxide [Partial pressure] in Venous blood

1430

6498

1.15

5.60

3.2

4.9

5.88

5.80

kpa

2.08

1373

6277

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

133

433

1.60

5.59

4.4

4.8

33.54

100.84

u/ml

1.31

139

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

2.45

5.57

1.1

0.24

3.22

u/ml

1.25

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

255

951

1.40

5.57

1.2

31.65

41.49

u/l

0.65

223

817

(3045683) HLA typing for celiac disease panel - Blood or Tissue

262

1.77

5.41

1.0

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

2.47

5.40

1.3

1.7

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

174

608

1.49

5.37

1.0

1.1

—

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

118

377

1.63

5.36

1.6

1.7

22.86

29.47

u/ml

0.79

(3028679) Herpes simplex virus Ab [Presence] in Serum

117

373

1.63

5.36

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

238

884

1.40

5.35

1.2

—

(3002079) Sodium [Moles/time] in 24 hour Urine

248

1.78

5.33

1.5

1.1

151.70

153.26

mmol/24h

0.06

248

(1616796) Gas panel - Central venous blood

410

1656

1.29

5.31

3.9

4.4

—

(3020123) Porphyrins [Interpretation] in Serum or Plasma

3.80

5.27

1.3

1.0

—

(3007463) Buprenorphine [Presence] in Urine

4.37

5.22

5.1

3.2

—

(3014271) Vancomycin [Susceptibility]

305

1.69

5.17

2.9

3.0

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.23

5.16

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

564

0.54

5.15

1.3

1.4

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

233

1.79

5.07

1.4

1.7

5.34

9.42

ug/l

1.50

217

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

101

315

1.67

5.06

1.4

1.3

77.78

614.71

titre

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

933

5643

0.85

5.05

1.5

1.6

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

2812

13402

1.10

5.02

1.7

1.8

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

103

324

1.65

5.00

1.6

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

190

687

1.44

4.98

1.2

1.1

—

(3011985) Renin [Units/volume] in Plasma

197

718

1.43

4.95

1.4

1.6

79.86

52.17

mu/l

0.83

173

643

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

109

349

1.62

4.95

1.2

5.95

5.88

umol/l

0.06

327

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

704

3054

1.20

4.86

2.4

3.4

0.62

0.68

4.17

698

3040

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

167

592

1.47

4.85

2.3

3.1

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

404

1650

1.28

4.84

1.2

1.4

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

721

3136

1.20

4.84

2.4

3.5

1.33

1.22

1.23

714

3117

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

153

534

1.49

4.80

1.1

—

(3037756) Immunofixation for Serum or Plasma

309

1220

1.32

4.77

1.4

1.6

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

2.97

4.76

1.1

1.66

1.62

umol/24h

0.08

(3006270) Folate [Moles/volume] in Blood

145

502

1.50

4.74

1.2

1.1

385.62

348.91

nmol/l

1.13

129

390

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

204

1.81

4.72

1.1

1.2

—

(3000330) Specific gravity of Urine by Test strip

789

3474

1.19

4.64

3.5

3.6

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

161

1.91

4.59

1.1

1.0

—

(3036489) Thrombin time

587

2519

1.22

4.55

1.9

2.5

21.28

21.58

0.46

523

2249

(3006184) Hemoglobin [Mass/volume] in Capillary blood

383

1571

1.27

4.47

2.1

2.5

129.82

128.05

g/l

0.55

269

1253

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

623

2695

1.21

4.46

1.8

2.1

2.67

2.29

ug/l

0.20

544

2400

(3013005) Retinol [Moles/volume] in Serum or Plasma

212

1.77

4.45

2.1

2.02

1.89

umol/l

0.69

200

(3048879) Bone marrow aspiration report

141

1.95

4.44

1.4

2.0

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.70

4.43

1.1

1.0

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

2.70

4.43

1.6

46.31

46.24

umol/l

0.00

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

224

854

1.37

4.39

1.2

1.6

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

7.14

4.39

1.1

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

282

1117

1.32

4.30

2.0

2.3

5.05

6.70

umol/l

1.81

199

844

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

2.38

4.28

1.0

1.1

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

310

1.61

4.28

1.1

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

140

1.93

4.24

1.2

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

193

1.78

4.20

1.0

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

532

2281

1.22

4.20

1.3

221.53

235.99

miu/ml

0.37

244

1013

(3020891) Body temperature

535

2298

1.21

4.15

4.1

5.6

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

7.42

4.11

1.0

—

(3021901) Oxygen saturation in Capillary blood

333

1359

1.28

4.09

2.7

3.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

2.29

4.09

1.0

1.1

—

(3003181) Sodium [Moles/volume] in Urine

270

1072

1.31

4.08

1.3

1.4

63.68

61.06

mmol/l

0.46

215

842

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

103

2.07

4.03

1.0

1.1

—

(3008295) Osmolality of Serum or Plasma

165

607

1.41

4.03

1.4

1.5

281.15

283.88

mosm/kgh2o

0.61

118

481

(3024869) Neuronal Ab [Presence] in Serum

2.26

3.98

1.1

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

213

1.71

3.92

1.4

1.7

4.39

12.97

nmol/l

0.37

185

(3020779) Urea [Moles/volume] in Serum or Plasma

1402

6523

1.13

3.91

5.4

10.9

10.32

11.04

mmol/l

2.81

1325

6220

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

179

0.32

3.82

4.4

8.5

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

177

668

1.38

3.76

1.3

1.4

315.38

375.87

pmol/l

0.60

155

580

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

154

1.82

3.76

1.2

10.00

19.04

—

(3043410) Blood group antigens tested for on Red Blood Cells

166

1.78

3.72

1.2

1.6

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

2.54

3.71

1.0

0.02

0.23

u/ml

1.07

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

201

1.71

3.71

1.3

1.5

16.33

15.12

pmol/l

0.33

172

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

277

1.60

3.71

1.5

1.9

—

(3024471) HLA-A [Type]

392

0.54

3.70

1.0

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

245

1.63

3.69

1.3

1.2

448.33

246.10

u/l

0.71

231

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

118

1.94

3.67

1.1

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

278

1.59

3.66

1.5

1.9

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

160

1.79

3.61

1.3

1.2

0.28

0.30

g/l

1.11

129

(3024932) HLA-DR beta [Type]

382

0.54

3.61

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

2.09

3.57

1.2

1.1

0.70

0.63

umol/24h

0.59

(3019060) Gas panel - Arterial blood

909

4139

1.15

3.56

3.8

5.3

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

340

1417

1.25

3.56

1.6

—

(3025130) Human papilloma virus identified in Specimen

193

746

1.35

3.56

1.6

1.8

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

156

583

1.39

3.54

1.4

1.8

—

(3042631) Mycobacterium sp identified in Specimen

209

821

1.33

3.47

2.9

2.5

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

262

1.59

3.45

1.3

1.6

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

262

1.59

3.45

1.4

1.6

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

110

1.94

3.44

1.1

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

198

1.68

3.43

1.1

95.53

80.47

1.84

107

(3006653) Thiamine [Moles/volume] in Blood

238

1.62

3.43

1.4

1.2

135.34

133.54

nmol/l

0.13

238

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

187

1.70

3.38

1.1

705.50

411.04

ng/l

0.23

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

284

1.56

3.38

6.3

6.6

—

(3051339) Copper [Moles/volume] in Blood

3.55

3.37

1.2

17.79

16.82

umol/l

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

2.01

3.35

1.3

1.2

124.14

55.30

mg/l

0.22

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

2.40

3.33

1.0

0.12

1.23

u/ml

0.66

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

119

1.88

3.31

1.1

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

108

1.92

3.31

1.2

1.5

9.16

10.13

ug/l

0.64

108

(3020650) Glucose [Presence] in Urine

127

1.84

3.28

1.7

1.2

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

259

1057

1.28

3.27

1.5

1.8

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

422

0.59

3.24

1.1

1.2

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

2.97

3.23

1.1

1.0

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

356

1510

1.23

3.22

1.5

1.7

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

147

1.77

3.21

1.3

1.2

110.34

116.01

0.87

131

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

132

489

1.40

3.19

1.2

1.4

—

titre

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

413

0.59

3.18

1.1

—

(3047189) Immunofixation for 24 hour Urine

236

1.59

3.13

1.7

1.6

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

123

452

1.42

3.12

1.4

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

123

452

1.42

3.12

1.4

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

123

452

1.42

3.12

1.4

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

332

1.49

3.11

1.3

1.2

1.54

1.52

g/l

0.16

332

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

274

1.54

3.08

1.2

1.4

84.89

61.41

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

157

1.72

3.07

1.2

1.1

3.30

67.22

u/ml

0.50

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

2.76

3.07

1.6

1.5

0.64

4.11

mg/l

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

134

502

1.39

3.05

1.3

130.40

195.47

titre

0.53

(3018405) Lactate [Moles/volume] in Arterial blood

472

2070

1.19

3.04

3.1

4.6

1.51

1.47

mmol/l

0.26

461

2017

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

123

1.82

3.03

1.1

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

3.67

2.97

1.0

1.5

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

128

1.79

2.95

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

315

1.49

2.95

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

118

436

1.41

2.92

1.1

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

117

1.82

2.92

1.0

1.1

—

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

2.68

2.92

1.0

1.1

5.65

12.12

u/ml

0.71

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

138

524

1.37

2.92

1.3

1.6

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

218

885

1.28

2.91

1.8

2.0

4394.29

2672.00

titre

0.19

(3051387) C reactive protein [Mass/volume] in Capillary blood

335

1429

1.22

2.91

3.6

2.7

25.47

31.59

mg/l

2.27

220

967

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

235

0.49

2.90

2.8

1.9

14884.77

13378.16

e6/l

0.06

129

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

774

3543

1.14

2.88

8.0

10.6

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

133

1.76

2.88

1.3

175.68

127.74

nmol/l

0.63

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

2.42

2.85

1.0

1.1

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

140

536

1.36

2.83

1.5

1.8

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

227

931

1.27

2.81

1.1

—

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

210

1.58

2.81

1.2

113.02

101.12

1.32

198

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

2.29

2.80

1.0

0.03

0.15

u/ml

1.41

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

2.53

2.80

1.1

—

(40768793) Breast Pathology biopsy report

216

881

1.28

2.80

1.3

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

202

1.60

2.80

1.1

98.00

82.06

3.26

108

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

3.99

2.75

1.1

4.4

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

282

1787

0.82

2.74

4.0

7.5

1292.97

751.87

iu/ml

0.34

326

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

128

1.75

2.70

1.1

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

362

1.42

2.64

1.3

1.5

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

263

1107

1.24

2.63

2.6

5.3

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

101

371

1.42

2.63

1.3

1.5

—

(3011648) Oxygen content in Venous blood

132

508

1.35

2.61

1.7

2.8

10.55

11.06

0.62

132

508

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

159

630

1.31

2.59

1.1

1.2

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

3.71

2.58

1.0

1.6

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

2.00

2.55

3.6

2.7

—

(3040151) Glucose [Moles/volume] in Capillary blood

207

851

1.27

2.55

7.7

18.4

7.21

7.45

mmol/l

0.43

173

702

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

287

1.47

2.55

2.2

2.5

49.07

52.42

umol/l

0.38

247

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

339

1472

1.20

2.51

1.5

1.8

—

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

2.26

2.51

1.0

0.03

0.46

u/ml

0.74

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

162

1080

0.78

2.51

1.1

1.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

217

1.53

2.48

1.6

2.1

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

217

1.53

2.48

1.6

2.1

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

209

864

1.26

2.47

6.2

7.0

12.03

11.70

mg/l

0.48

188

795

(3012989) Citrate [Moles/time] in 24 hour Urine

5.19

2.47

1.3

2.1

1.94

1.50

mmol/24h

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

164

1.62

2.46

1.1

1.0

10.36

13.65

u/ml

0.39

(3013293) Extractable nuclear Ab [Presence] in Serum

2.10

2.44

1.3

2.0

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

2.04

2.40

1.0

0.02

0.18

u/ml

1.29

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

220

1.51

2.35

1.6

2.1

—

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

2.51

2.34

1.5

1.89

3.45

mg/l

—

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

2.51

2.34

1.5

0.33

3.72

mg/l

—

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

2.51

2.34

1.5

3.35

3.36

mg/l

—

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

2.51

2.34

1.5

0.58

3.22

mg/l

—

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

2.51

2.34

1.5

1.69

3.05

mg/l

—

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

2.51

2.34

1.5

0.93

4.11

mg/l

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

2.51

2.34

1.0

1.1

—

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

2.51

2.34

1.5

1.30

3.65

mg/l

—

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

2.51

2.34

1.5

0.53

0.75

mg/l

—

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

2.51

2.34

1.5

3.29

2.80

mg/l

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

108

411

1.37

2.33

1.1

—

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

294

1.43

2.29

2.1

69.59

142.19

ug/min

0.80

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

1.97

2.28

2.2

2.1

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

373

1.38

2.28

1.3

1.4

5.79

5.38

mmol/l

0.94

356

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

174

1134

0.79

2.26

2.3

2.5

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

137

0.42

2.26

1.1

2.3

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

2.10

2.25

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

119

463

1.34

2.24

1.1

1.2

—

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

219

922

1.24

2.24

1.1

1.2

119.76

109.79

4.39

197

854

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

3.78

2.19

1.1

1.0

—

mmol/l

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

3.78

2.19

1.0

1.1

—

(3015147) Influenza virus A IgG Ab [Units/volume] in Serum

5.19

2.17

1.0

1.3

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

158

1.58

2.15

1.8

1.9

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

106

409

1.35

2.13

1.1

—

(3010503) CD19 cells [#/volume] in Blood

359

1.36

2.03

2.2

2.7

0.20

0.44

e9/l

0.53

350

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

100

1.71

2.03

1.1

1.2

259.86

488.51

pmol/l

0.75

(3016038) Potassium [Moles/volume] in Urine

104

404

1.34

2.02

1.3

1.2

34.10

33.69

mmol/l

0.06

356

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

233

1.45

2.00

1.3

1.2

—

(1617658) Protocol used for examination of sentinel lymph nodes

268

1.42

1.99

1.0

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

269

1.41

1.95

1.6

1.7

—

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

268

1171

1.19

1.94

2.9

3.4

307.11

1120.54

u/ml

0.81

248

1057

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

104

407

1.33

1.94

1.8

1.9

4.48

5.03

mg/l

0.49

387

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

138

563

1.27

1.90

2.2

2.0

1.98

2.03

u/field

0.03

210

(3001556) Androgen free Index in Serum or Plasma

1.83

1.90

1.3

1.2

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

180

758

1.23

1.90

1.5

1.8

—

(3015350) Toxocara sp Ab [Presence] in Serum

5.19

1.87

1.0

—

(40759632) Porphyrins [Mass/mass] in Stool

5.19

1.87

1.2

1.0

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

2.49

1.87

1.2

1.1

—

(3044007) Cell count panel - Peritoneal fluid

201

0.57

1.86

2.3

2.1

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

206

883

1.21

1.84

1.5

1.7

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

169

1.51

1.84

2.2

2.0

—

(21494890) Protein electrophoresis panel - 24 hour Urine

143

589

1.26

1.84

2.0

1.8

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

235

1021

1.20

1.83

1.4

1.8

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

235

1021

1.20

1.83

1.4

1.8

—

(3017569) Oxygen content in Arterial blood

304

1.37

1.82

1.9

2.3

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

581

0.75

1.81

1.1

1.3

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

120

1.60

1.81

1.5

1.9

118.63

163.89

ng/l

0.92

120

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

312

1391

1.17

1.80

1.7

2.9

0.91

0.81

nmol/l

1.64

260

1161

(3043409) Potassium [Moles/volume] in Arterial blood

386

1750

1.15

1.79

3.3

4.9

3.91

3.93

mmol/l

0.32

379

1727

(3006567) Chloride [Moles/time] in 24 hour Urine

3.89

1.78

1.8

1.3

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

2.33

1.78

1.5

1.2

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

2.33

1.78

1.0

—

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

167

704

1.23

1.77

1.1

1.2

98.33

90.55

3.05

155

671

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

188

1.46

1.76

1.1

—

(3029612) Listeria sp Ab [Titer] in Serum

3.30

1.76

1.4

1.2

—

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

167

1.49

1.75

2.3

3.5

—

(3051611) Lipemic interference index of Serum or Plasma

157

659

1.24

1.73

2.9

3.6

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.73

1.73

1.0

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

138

1.54

1.73

1.1

1.2

61.63

76.22

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

106

424

1.30

1.73

1.5

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

125

511

1.27

1.73

1.5

1.6

—

(3001729) Color of Synovial fluid

2.20

1.72

1.9

1.4

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

1.93

1.71

1.1

1.0

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

139

578

1.25

1.68

1.4

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

2.25

1.67

1.1

1.0

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

135

869

0.80

1.67

1.5

1.7

8.26

7.43

mmol/l

2.43

127

823

(3004775) Volume in Urine collected for unspecified duration

113

742

0.79

1.66

2.0

2.6

609.37

676.87

1.11

531

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

314

1.34

1.65

1.9

3.0

874.54

1096.87

u/ml

0.53

307

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

2.03

1.63

1.2

1.1

15.63

7.10

u/l

0.89

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

3.03

1.62

1.0

1.2

5.14

3.00

—

(3012565) Volume of 24 hour Urine

320

1.33

1.61

2.3

2.4

2014.55

1767.13

1.30

282

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

127

526

1.26

1.60

1.4

1.3

1.60

1.37

nmol/l

1.25

115

479

(4212803) Bone marrow aspirate examination

1.96

1.60

1.1

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

884

4230

1.09

1.59

2.9

4.1

131.60

126.81

g/l

7.99

853

4143

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

430

1982

1.13

1.59

2.2

3.1

179.54

191.66

2.00

407

1898

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

137

1.52

1.59

1.1

1.2

74.00

83.04

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

2.38

1.59

1.0

—

(3044242) Glucose [Moles/volume] in Arterial blood

313

1.33

1.55

1.6

2.0

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

260

0.66

1.55

2.3

2.1

3751.81

2960.93

e6/l

0.08

184

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

144

608

1.23

1.54

1.1

1.2

58.82

66.97

u/l

0.73

137

559

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

309

1.33

1.54

3.9

3.6

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

265

1.35

1.52

2.7

130.88

98.49

au/ml

0.27

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

246

1095

1.17

1.51

1.1

99.97

926.39

iu/ml

0.53

230

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

1.87

1.50

1.1

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

1.87

1.50

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

2.80

1.50

1.0

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

293

1.33

1.49

5.9

8.0

1019.83

9727.51

u/ml

0.61

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

343

0.71

1.49

6.8

6.0

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

343

0.71

1.49

3.4

3.0

—

(3051101) Glucose [Moles/volume] in Cord blood

168

0.59

1.48

6.4

5.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

161

0.58

1.46

2.9

2.8

—

(1761482) Bacteria [#/volume] in Urine by Culture

355

2081

0.88

1.46

4.7

3.8

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

175

1.42

1.44

1.1

1.2

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

345

1.30

1.43

1.6

—

(3000060) B lymphocytes [#/volume] in Blood

158

1.45

1.43

1.7

2.1

156.67

615.83

e6/l

0.45

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

278

1256

1.15

1.42

1.3

1.2

5.48

4.10

ug/l

0.45

262

1173

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

2.15

1.42

1.1

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

347

1.29

1.38

1.6

—

(3018001) Oat IgE Ab [Units/volume] in Serum

2.05

1.37

1.0

1.1

0.25

0.31

u/ml

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

361

1.28

1.37

1.5

1.6

6.68

7.74

u/l

0.28

287

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

133

836

0.82

1.36

1.4

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

466

2182

1.11

1.36

3.2

3.4

2053.08

1246.83

u/ml

0.20

380

1882

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

2.83

1.36

1.7

1.0

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

170

0.61

1.35

1.3

1.4

25.84

27.29

g/l

0.13

143

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

147

1.45

1.35

2.2

2.1

12.57

17.79

umol/l

3.15

147

(3011412) CD3 cells [#/volume] in Blood

136

581

1.22

1.35

2.2

2.5

1.30

1.05

e9/l

1.91

119

518

(3028714) Urate [Moles/time] in 24 hour Urine

3.24

1.34

1.2

1.1

—

(3041184) Isoniazid [Presence] in Urine

3.24

1.34

1.8

2.6

—

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

1.62

1.34

3.5

2.7

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

109

1.52

1.34

1.1

1.2

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

1.66

1.34

1.3

1.2

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

404

1.26

1.34

1.5

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

201

891

1.17

1.33

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

2.23

1.32

1.1

1.0

204.92

213.71

nmol/l

—

(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose

2.23

1.32

1.1

1.0

8.60

8.55

mmol/l

—

(3045142) Bone marrow Pathology biopsy report

150

649

1.20

1.31

1.2

1.4

—

(3000093) Morphology [Interpretation] in Blood Narrative

149

645

1.20

1.30

1.1

1.2

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

1.60

1.29

2.2

1.9

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

229

1030

1.16

1.28

1.2

1.3

3.17

4.62

u/ml

0.52

376

(40768441) Liver Pathology biopsy report

100

417

1.25

1.26

1.6

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

305

1403

1.13

1.24

1.6

—

(40768795) Lymph node Pathology biopsy report

116

493

1.22

1.23

1.2

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.45

1.23

2.0

3.3

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

165

0.63

1.22

8.4

11.1

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

383

0.76

1.21

1.3

8.7

65.65

1017.72

mg/l

0.84

291

(3005082) Progesterone [Moles/volume] in Serum or Plasma

123

527

1.21

1.4

30.80

34.99

nmol/l

1.00

108

503

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

2.88

1.21

1.2

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.88

1.21

1.0

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

290

1.29

1.20

1.1

1.2

97.24

92.13

u/l

0.13

260

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

415

1.24

1.20

2.1

2.8

827.68

571.27

e6/l

1.82

403

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

1.55

1.19

1.7

1.4

376196.46

82900.42

nmol/l

0.34

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

0.52

1.19

1.0

1.2

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

220

993

1.15

1.19

1.3

3.11

4.12

u/ml

1.10

483

(3020876) Protein [Mass/time] in 24 hour Urine

179

796

1.17

1.18

2.5

2.6

1.18

1.34

g/24h

0.35

471

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

193

864

1.16

1.17

1.4

1.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

333

1.26

1.17

1.4

1.5

1.15

1.18

nmol/l

0.10

270

(3017704) Immunofixation for Urine

347

1.26

1.16

1.4

1.5

—

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

363

2089

0.90

1.15

2.8

4.2

1.59

1.72

mg/l

1.94

330

1931

(4034850) Laboratory test

407

1914

1.11

1.14

11.6

9.5

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

198

1.34

1.12

2.3

2.9

27.80

29.20

umol/l

0.39

143

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

289

1.28

1.12

1.1

1.2

34.58

28.56

u/l

0.21

258

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

1.82

1.11

1.4

1.8

20.90

22.02

mmol/l

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

1.77

1.10

1.5

2.3

—

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

232

1366

0.88

1.10

2.0

3.5

1266.36

9511.80

u/ml

0.64

(40761539) Cells [Type] in Urine sediment by Light microscopy

154

1.38

1.10

1.1

1.4

—

(3022689) Creatine [Moles/volume] in Urine

168

1.36

1.08

1.3

1.5

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

398

1.23

1.07

2.1

2.7

612.88

496.86

e6/l

0.56

327

(3018834) Bilirubin.total [Presence] in Urine by Test strip

2.03

1.06

1.2

3.6

—

0.00

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

341

1598

1.11

1.05

1.1

1.3

—

(3023183) Ammonium ion [Moles/volume] in Plasma

311

1451

1.11

1.04

2.9

2.6

37.53

31.94

umol/l

1.11

283

1305

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

0.00

1.03

0.0

1.2

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

121

1.42

1.02

1.1

1.2

—

(3029396) Erythrocyte agglutination [Presence] in Blood

325

0.77

1.01

2.7

3.2

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

180

813

1.15

1.01

1.4

—

(3038515) Glucose [Moles/volume] in Venous blood

296

1705

0.90

0.99

3.3

3.4

7.30

7.93

mmol/l

2.88

284

1681

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

207

1.30

0.99

2.6

2.4

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

1.87

0.98

1.1

1.2

—

(3009677) Dengue virus Ab [Presence] in Serum

2.02

0.97

1.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

205

938

1.14

0.96

1.4

1.5

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

385

1.21

0.96

2.1

2.7

0.22

0.24

e9/l

0.38

324

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

194

886

1.14

0.94

2.7

2.9

113.82

1294.16

u/ml

0.87

188

873

(3014148) Varicella zoster virus Ab [Titer] in Serum

190

1117

0.88

0.92

1.2

—

(3013637) Mi-2 Ab [Presence] in Serum

102

1.43

0.92

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

102

1.43

0.92

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

102

1.43

0.92

1.1

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

102

1.43

0.92

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

378

1.21

0.91

1.1

1.2

1.04

1.08

ratio

1.16

135

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

303

1.23

0.90

3.0

3.3

7.14

8.55

mg/l

1.06

244

(3000034) Microalbumin [Mass/volume] in Urine

132

589

1.16

0.90

2.8

3.2

25.82

73.76

mg/l

2.33

425

(3008152) Bicarbonate [Moles/volume] in Arterial blood

821

4022

1.06

0.89

5.5

7.6

24.40

24.36

mmol/l

0.10

781

3822

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

1.54

0.89

1.2

1.0

40.21

49.55

mg/l

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

346

1.22

0.89

1.8

2.88

3.35

u/field

0.21

255

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

1.44

0.89

1.0

1.2

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

170

1.31

0.88

1.2

1.3

—

(3008037) Lactate [Moles/volume] in Venous blood

313

1783

0.91

0.88

3.2

3.3

1.53

1.71

mmol/l

3.21

298

1753

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

1.58

0.87

1.3

1.2

129.00

110.75

ug/l

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

1.49

0.87

1.1

—

(3033799) Differential panel - Peritoneal fluid

217

0.74

0.86

1.8

2.1

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

203

1.28

0.85

1.1

1.2

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

187

0.72

0.85

7.4

10.6

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

113

0.64

0.83

8.8

7.7

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

430

1.18

0.83

2.9

2.1

96.38

97.13

0.08

411

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

302

1.22

0.83

1.0

41.48

44.49

ng/l

0.26

211

(3020393) Adenovirus Ag [Presence] in Stool

1.55

0.82

1.0

1.1

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

1.59

0.80

1.0

1.1

—

(3028433) Virus identified in Specimen by Culture

182

1.28

0.80

1.5

1.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

446

2150

1.08

0.80

2.1

2.7

91.74

91.05

0.25

432

2084

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

2.36

0.79

1.2

2.6

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

236

1106

1.11

0.79

1.4

1.6

—

(40757494) Bilirubin.total [Moles/volume] in Blood

286

1.22

0.77

2.0

2.1

8.09

24.88

umol/l

—

(21494814) CD8 cells/100 lymphocytes in Specimen

244

1.23

0.76

2.1

1.9

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

206

0.76

0.75

6.0

5.7

67.29

70.89

0.34

169

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

1.56

0.75

1.0

1.1

6.40

13.59

iu/ml

—

(3000012) Reticulocyte production index

218

1021

1.11

0.75

2.2

—

(21494434) Karyotype in Bone marrow

116

522

1.15

0.75

1.2

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

1.67

0.75

1.0

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

203

1.25

0.74

2.2

1.9

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

302

1.20

0.73

1.0

798.32

702.24

ng/l

1.01

205

(3037692) Legionella sp identified in Specimen by Organism specific culture

240

0.78

0.73

1.4

1.7

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.50

0.73

1.0

1.1

—

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

1.44

0.72

1.1

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

298

1.20

0.72

1.0

287.47

334.01

ng/l

0.70

211

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

1.73

0.72

1.0

—

(3047181) Lactate [Moles/volume] in Blood

432

2092

1.07

0.71

4.9

6.4

1.30

1.33

mmol/l

0.25

384

1869

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

455

2210

1.07

0.70

2.5

3.0

3.63

3.58

g/l

0.26

428

2109

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

1.46

0.70

1.3

1.2

0.97

0.92

ml/s/173m2

0.07

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

1.47

0.68

1.8

1.4

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

1.57

0.68

1.4

1.3

—

(3050794) Legionella sp Ab [Presence] in Serum

1.57

0.68

1.0

1.1

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

248

1178

1.09

0.67

2.4

2.3

4.22

9.50

titre

—

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

1.43

0.67

1.1

1.0

0.03

0.04

u/ml

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

1.48

0.67

1.3

1.2

—

(3004451) EKG impression Narrative

316

1.18

0.65

1.2

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.45

0.64

1.0

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

343

0.83

0.64

3.5

3.4

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

318

1531

1.08

0.64

1.1

1.4

268.42

270.61

u/ml

0.04

197

1043

(3016750) Collection duration of Urine

533

0.87

0.64

1.7

2.6

485.16

502.81

min

0.87

435

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.56

0.62

1.0

1.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

279

1564

0.92

0.61

1.3

1.7

99.48

112.73

u/ml

1.40

354

(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method

0.00

0.61

0.0

1.0

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

1.38

0.61

2.4

2.6

0.75

0.44

u/field

0.75

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

1.38

0.61

1.1

1.6

—

(3036525) Urea [Moles/time] in 24 hour Urine

0.65

0.61

2.5

2.8

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

107

1.31

0.59

2.7

2.2

124.11

82.39

ng/l

0.62

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

205

1.22

0.59

1.1

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

318

1538

1.07

0.58

1.4

—

(40758292) HTLV I+II Ab panel - Serum

103

1.31

0.58

1.2

1.4

—

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

1.37

0.57

1.2

0.24

0.21

nmol/l

0.12

(3032352) Blasts [#/volume] in Cerebral spinal fluid

1.44

0.56

1.0

2.6

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

178

1.23

0.56

1.4

27.09

20.16

0.88

140

(37021550) Renin [Units/volume] in Plasma --upright

1.31

0.56

1.6

1.4

95.47

100.98

mu/l

0.05

(46235168) Fasting glucose [Moles/volume] in Blood

1.31

0.56

1.1

3.5

8.44

7.40

mmol/l

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

351

1.15

0.55

1.1

1.2

103.82

101.50

u/l

0.05

321

(1175426) CD3 cells/100 lymphocytes in Blood

103

473

1.13

0.55

2.1

2.0

72.96

72.42

0.12

455

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

118

1.28

0.54

1.1

1.3

—

(3017509) Phencyclidine [Presence] in Urine

1.31

0.54

1.6

2.5

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

0.59

0.54

3.2

2.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

1.57

0.54

1.0

1.1

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

1.57

0.54

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

596

2950

1.05

0.53

1.5

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

212

1014

1.09

0.53

1.5

1.6

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

213

1.19

0.52

1.2

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.42

0.52

1.0

1.1

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

0.67

0.52

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

337

1644

1.07

0.51

2.1

2.6

118.62

113.54

ug/min

0.06

207

1047

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

447

1.13

0.50

2.1

—

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

278

1.16

0.48

1.5

59.68

65.84

0.57

223

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.60

0.48

1.6

1.3

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.59

0.48

1.6

1.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

150

711

1.10

0.48

1.4

6.18

6.46

mmol/l

0.42

136

666

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.58

0.48

1.0

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

530

2879

0.95

0.47

4.3

5.3

0.84

0.87

1.28

505

2728

(3025549) Creatine [Moles/time] in 24 hour Urine

1.36

0.46

1.3

—

(3039000) Anion gap in Blood

270

1494

0.94

0.46

5.9

7.4

11.65

11.29

mmol/l

1.05

247

1364

(3018572) Chloride [Moles/volume] in Blood

270

1494

0.94

0.46

5.9

7.4

105.17

104.99

mmol/l

0.25

247

1364

(3027273) Bicarbonate [Moles/volume] in Venous blood

650

3512

0.96

0.46

3.2

4.2

25.29

24.93

mmol/l

1.76

623

3405

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

380

0.87

0.45

2.4

2.8

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.70

0.45

1.2

1.7

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

412

1.12

0.45

1.1

1.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

545

2708

1.05

0.45

2.7

3.4

0.37

0.34

u/ml

0.86

311

1526

(46235689) Lupus anticoagulant aPTT, dRVVT and PT screening panel W Reflex

143

680

1.09

0.44

2.5

2.4

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.62

0.43

5.6

7.1

6.48

11.18

mg/l

—

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

262

1.15

0.42

1.1

98.00

94.15

0.42

218

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

104

1.25

0.42

1.2

1.0

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

1.38

0.41

1.0

1.1

—

(3023199) Leukocytes [#/volume] in Pleural fluid

189

914

1.07

0.40

1.5

1988.27

1704.51

e6/l

0.35

130

655

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

342

1.12

0.40

1.1

1.2

25.37

25.70

u/l

0.02

311

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

386

0.89

0.39

2.6

2.8

42.06

38.45

0.66

200

(3028717) Thiamine [Mass/volume] in Blood

1.35

0.39

1.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.68

0.39

1.4

1.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

1.33

0.38

1.2

—

(3041672) Baker's yeast Ab [Presence] in Serum

1.33

0.38

1.0

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

1.30

0.38

1.0

1.1

—

(3006245) CD3-CD19+ cells/100 cells in Blood

236

1.14

0.37

2.0

2.1

7.98

10.45

0.73

215

(3028308) Erythrocytes [#/volume] in Pleural fluid

172

833

1.07

0.37

1.4

99063.19

42573.27

e6/l

0.78

481

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

198

1.15

0.36

1.4

1.2

760.27

40.77

ug/l

0.74

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

266

1455

0.95

0.35

1.8

1.7

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

147

710

1.08

0.34

1.3

601.76

558.08

u/l

0.05

137

671

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

114

545

1.09

0.34

1.3

16.23

15.03

u/l

0.16

105

492

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

1.28

0.33

1.9

2.2

2.02

1.14

mmol/l

—

(3034426) Prothrombin time (PT)

229

1.13

0.33

1.3

—

(3051651) Icteric interference index of Serum or Plasma

417

1.10

0.33

3.0

4.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

207

1137

0.94

0.32

1.1

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

0.71

0.32

1.1

1.4

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

137

1.17

0.32

1.2

1.6

38.57

88.07

ng/l

1.36

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

300

1.11

0.30

1.1

1.3

—

(40757373) Influenza virus identified in Isolate

192

0.86

0.30

1.3

1.5

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

534

2685

1.03

0.29

1.8

1.9

—

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

0.80

0.29

1.3

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

550

2769

1.03

0.28

1.4

1.5

—

(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay

356

1.09

0.28

4.2

3.0

24.21

56.39

u/ml

2.54

347

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

1.26

0.28

1.0

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

113

0.83

0.28

1.1

1.5

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

218

0.88

0.28

1.9

2.5

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

218

0.88

0.28

1.9

2.5

—

(3016031) Almond IgE Ab [Units/volume] in Serum

1.33

0.27

1.0

0.26

0.86

u/ml

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

515

0.93

0.27

1.8

2.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

545

2909

0.97

0.25

4.2

5.2

1.65

1.64

0.09

517

2753

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

552

2787

1.03

0.25

1.4

1.5

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

552

2789

1.03

0.24

1.4

1.5

—

(40758358) Immune stain study

1.37

0.24

1.0

—

(4281824) Cell count and differential, peritoneal fluid

104

576

0.94

0.24

1.2

—

(3000285) Sodium [Moles/volume] in Blood

1.20

0.24

1.0

1.1

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

1.23

0.23

2.8

5.0

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

1.17

0.23

1.7

1.9

2.50

2.82

ug/l

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

1.27

0.22

1.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

360

0.92

0.22

1.0

—

(3000690) Aldosterone [Moles/time] in 24 hour Urine

0.00

0.22

0.0

1.2

—

37.00

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

110

0.85

0.22

6.1

5.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

0.82

0.21

3.0

2.6

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

189

1023

0.96

0.21

2.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

548

2778

1.02

0.20

1.4

1.5

—

(40763470) Parainfluenza virus 4 RNA [Presence] in Isolate by NAA with probe detection

151

748

1.05

0.20

1.4

1.7

—

(40763324) Parainfluenza virus 1 RNA [Presence] in Isolate by NAA with probe detection

151

749

1.05

0.19

1.4

1.7

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.24

0.19

1.1

1.0

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

227

1221

0.96

0.19

4.5

5.8

328.58

380.38

umol/l

6.04

193

1089

(3035880) pH of Pleural fluid

430

1.06

0.19

1.4

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

420

1.06

0.19

1.3

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

311

1661

0.97

0.18

1.3

1.7

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

1.16

0.17

1.0

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.19

0.17

1.0

—

(3030313) Adrenal Ab [Titer] in Serum

1.21

0.16

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

1.12

0.16

1.1

—

(3019174) dRVVT (LA screen)

1.20

0.16

1.2

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

291

1550

0.97

0.15

2.9

3.1

0.89

0.80

nmol/l

1.46

215

1190

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

267

0.93

0.15

2.1

2.0

4170.78

41554.12

u/ml

—

(3021162) Amylase [Enzymatic activity/volume] in Specimen

1.12

0.14

1.9

2.7

4040.33

1369.15

u/l

0.47

(44786800) Granulocytes/100 leukocytes in Body fluid

102

1.12

0.14

1.4

27.87

23.96

0.16

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

627

3202

1.02

0.14

3.7

4.5

48.38

47.79

0.23

615

3168

(3034988) Calcium [Moles/volume] in Capillary blood

142

1.10

0.14

2.3

1.9

1.19

1.17

mmol/l

0.90

136

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

1.16

0.13

1.1

—

(40765096) Chromosome analysis panel by Banding

143

1.09

0.13

1.2

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.88

0.12

2.5

2.1

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

0.88

0.12

1.1

1.4

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

1.10

0.11

1.1

1.3

1489.81

87.45

u/l

0.46

(3001964) Herpes simplex virus Ag [Presence] in Specimen

200

1.06

0.11

1.1

1.7

—

(3012441) Differential panel - Pleural fluid

159

803

1.03

0.11

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

332

0.95

0.10

1.9

1.6

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

332

0.95

0.10

1.9

1.6

—

(40768806) Pleura Pathology biopsy report

159

804

1.03

0.10

1.6

1.5

—

(3019977) pH of Arterial blood

379

1.04

0.10

2.1

2.6

7.42

0.06

121

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

1.08

0.10

1.4

1.3

528.24

442.29

nmol/l

—

(3009871) Measles virus Ab [Titer] in Serum

209

0.94

0.09

1.7

1.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

193

0.94

0.09

1.1

1.2

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

105

1.09

0.09

1.3

1.2

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

109

583

0.97

0.09

1.7

1.9

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

145

0.93

0.09

2.5

1.9

1.18

mmol/l

0.18

140

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

129

0.93

0.09

1.7

1.5

2.29

12.93

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

1.10

0.09

1.5

1.2

19.44

20.53

u/l

0.07

(3005033) Fetal Nuchal fold Thickness US

448

2356

0.99

0.09

1.5

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

1.14

0.09

3.0

5.5

—

(3017461) Flecainide [Moles/volume] in Serum or Plasma

1.04

0.08

1.5

1.8

0.85

0.57

umol/l

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

245

0.95

0.08

1.6

1.5

1.06

2.59

2.00

204

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

0.84

0.08

1.0

—

(3024666) Lithium [Moles/volume] in Serum or Plasma

113

602

0.97

0.08

9.3

13.5

0.57

0.65

mmol/l

4.58

103

562

(3047352) Trisomy 18 risk [Likelihood] in Fetus

450

2363

0.99

0.08

1.5

—

(3006576) Bicarbonate [Moles/volume] in Blood

276

0.96

0.07

5.7

7.1

24.61

24.78

mmol/l

0.12

252

(3046861) Legionella sp Ag [Presence] in Urine

1.06

0.07

1.0

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

197

1004

1.02

0.07

1.3

1.4

7.31

6.87

mmol/l

1.17

174

867

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.83

0.07

2.0

1.3

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

1.09

0.07

1.4

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

365

0.97

0.07

1.1

1.3

—

(3003434) Protein [Mass/volume] in Pleural fluid

205

1046

1.02

0.07

1.5

31.25

30.52

g/l

0.36

179

921

(3011325) HIV 1+2 Ab [Presence] in Serum

1.06

0.07

1.1

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

467

2399

1.01

0.07

1.5

—

(3019832) Treponema pallidum Ab [Presence] in Serum

1974

10207

1.00

0.06

1.8

—

(3045788) Cell count panel - Pleural fluid

140

715

1.02

0.05

1.4

1.5

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

131

0.95

0.04

1.6

1.7

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

487

0.98

0.04

1.4

1.9

—

(3052592) Norovirus Ag [Presence] in Stool

144

1.05

0.04

1.3

1.6

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

319

1642

1.01

0.04

1.2

1.7

19.17

18.63

u/ml

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

134

1.05

0.04

1.1

1.3

1.64

1.44

mmol/l

0.29

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

413

0.98

0.04

1.1

1.3

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

344

0.98

0.03

1.1

1422.86

1521.31

miu/ml

0.29

344

(3008536) Aspergillus sp Ab [Presence] in Serum

130

1.04

0.02

1.4

3.0

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

1.05

0.02

1.2

1.0

—

(3042891) Cardiolipin IgM Ab [Mass/volume] in Serum

1.05

0.01

1.1

—

(3008607) Semen analysis panel

0.94

0.01

1.2

—

(3014891) Appearance of Pleural fluid

126

1.03

0.01

1.2

1.3

—

(3051593) INR in Capillary blood by Coagulation assay

360

1.01

0.00

6.7

15.5

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

1.02

0.00

1.1

—

(3044009) aPTT.lupus sensitive (LA screen)

0.98

0.00

1.1

1.2

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

112

1.02

0.00

1.0

1.3

0.97

mmol/l

0.01

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

101

526

1.00

0.00

1.3

1.4

12.36

13.36

umol/l

0.63

498

(3008116) Ketones [Moles/volume] in Urine by Test strip

142

0.99

0.00

1.5

1.3

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

0.96

0.00

1.2

1.1

—

(3022475) Manganese [Moles/volume] in Blood

0.92

0.00

1.5

1.2

—

(3041082) Glomerular basement membrane Ab [Titer] in Serum by Immunofluorescence

0.94

-0.00

1.0

—

(3022229) Phosphate [Moles/volume] in Urine

0.94

-0.00

1.0

1.2

22.90

20.20

mmol/l

—

(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH

0.84

-0.00

1.2

1.1

—

(3009992) Blasts/100 cells in Bone marrow

0.00

-0.00

0.0

1.4

—

25.00

—

(3010937) Rubella virus Ab [Presence] in Serum

0.93

-0.00

1.0

1.1

—

(3015956) Eosinophils/100 leukocytes in Blood by Manual count

0.87

-0.00

2.0

1.6

1.90

1.97

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

1.01

-0.00

1.3

1.0

—

(3005593) Pancreatic islet cell Ab [Titer] in Serum

0.00

-0.00

0.0

1.2

—

(40760512) CD34 cells/100 cells in Bone marrow

0.00

-0.00

0.0

1.0

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.04

-0.00

1.0

1.1

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

0.89

-0.00

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: RX_ACETICDERIV – Acetic acid derivatives and related substances

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

R13

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Acetic acid derivatives and related substances

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Acetic acid derivatives and related substances (RX_ACETICDERIV)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints